Quarterly Report • May 16, 2024
Quarterly Report
Open in ViewerOpens in native device viewer
KBC Group I Quarterly Report – 1Q2024 I p.1

Summary 3 Financial highlights 4 Overview of results and balance sheet 5 Analysis of the quarter 6 ESG developments, risk statement and economic views 9 Our guidance 11
Consolidated income statement 14
Consolidated statement of comprehensive income 15
Consolidated balance sheet 16
Consolidated statement of changes in equity 17
Consolidated cash flow statement 19
Notes to the accounting policies 20
Notes on segment reporting 22
Other notes 24
Additional information
Credit risk 39
Solvency 43
Income statement, volumes and ratios per business unit 49
Details of ratios and terms 57
The expectations, forecasts and statements regarding future developments that are contained in this report are, of course, based on assumptions and are contingent on a number of factors that will come into play in the future. Consequently, the actual situation may turn out to be (substantially) different.
'I Luc Popelier, Chief Financial Officer of the KBC Group, certify on behalf of the Executive Committee of KBC Group NV that, to the best of my knowledge, the abbreviated financial statements included in the quarterly report are based on the relevant accounting standards and fairly present in all material respects the financial condition and results of KBC Group NV including its consolidated subsidiaries, and that the quarterly report provides a fair view of the main events, the main transactions with related parties in the period under review and their impact on the abbreviated financial statements, and an overview of the main risks and uncertainties for the remainder of the current year.'
[email protected], KBC Group NV, Investor Relations Office, Havenlaan 2, 1080 Brussels, Belgium
This report contains information that is subject to transparency regulations for listed companies. Date of release: 16 May 2024

| KBC Group – overview (consolidated, IFRS) | 1Q2024 | 4Q2023 | 1Q2023 |
|---|---|---|---|
| Net result (in millions of EUR) | 506 | 677 | 882 |
| Basic earnings per share (in EUR) | 1.18 | 1.59 | 2.08 |
| Breakdown of the net result by business unit (in millions of EUR) | |||
| Belgium | 243 | 474 | 299 |
| Czech Republic | 197 | 102 | 184 |
| International Markets | 146 | 178 | 108 |
| Group Centre | -80 | -77 | 291 |
| Parent shareholders' equity per share (in EUR, end of period) | 54.9 | 53.9 | 51.9 |
'We recorded a net profit of 506 million euros in the first quarter of 2024. Compared to the result of the previous quarter, our total income benefited from several factors, including higher net interest income, net fee and commission income and insurance revenues, though these items were partly offset by lower levels of dividend income and trading & fair value income. Costs were up, since the bulk of the bank and insurance taxes for the full year are recorded – as usual – in the first quarter of the year. Disregarding bank and insurance taxes, costs fell by as much as 9% quarter-on-quarter and 1% year-on-year. Impairment charges too were down significantly, as the previous quarter had included a sizeable one-off impairment on goodwill.
Our loan portfolio continued to increase by 1% quarter-on-quarter and 4% year-on-year, with growth being recorded in each of the group's core countries. Customer deposits were up 1% quarter-on-quarter and 1% year-on-year, despite the outflow of deposits triggered by the issue of the retail State Note ('Staatsbon') in Belgium at the start of September 2023.
We have always been at the forefront of new digital developments, the most visible example of which being our personal digital assistant Kate, which we continuously develop further with the aim of ensuring maximum convenience for our customers. To date, around 4.5 million customers have already used Kate, up more than 40% on the year-earlier figure. Moreover, the proportion of cases resolved fully autonomously by Kate continues to improve and now stands at 65% in both Belgium and the Czech Republic, up from 57% and 54% respectively a year ago.
As regards our ongoing share buyback programme of 1.3 billion euros, we had already bought back approximately 15.3 million shares for a total consideration of approximately 0.9 billion euros by the end of April 2024. The programme is planned to run until 31 July 2024.
On 15 May 2024, we paid a final dividend of 3.15 euros per share, bringing the total dividend for full-year 2023 to 4.15 euros per share. In line with our announced capital deployment plan for full-year 2023, the Board of Directors has also decided to distribute the surplus capital above a fully loaded common equity ratio of 15% (approximately 280 million euros) in the form of an extraordinary interim dividend of 0.70 euros per share on 29 May 2024.
Our solvency position remained strong, with a fully loaded common equity ratio of 14.9% at the end of March 2024 (which already fully incorporates the effect of the ongoing share buyback programme of 1.3 billion euros and the extraordinary interim dividend of 0.70 euros per share). Not taking into account the extraordinary interim dividend, our common equity ratio would have been 15.2%. Our liquidity position remained very solid too, with an LCR of 162% and NSFR of 139%.
In closing, I would like to sincerely thank all our customers, employees, shareholders and other stakeholders for their trust and support. More than anything else, that trust and support is and remains fundamental to the success of our group, now and in the future.'

Johan Thijs Chief Executive Officer

• We place our customers at the centre of everything we do
Net interest income increased by 1% quarter-on-quarter and by 3% year-on-year. The net interest margin for the quarter under review amounted to 2.08%, up 9 basis points on the previous quarter and 4 basis points on the year-earlier quarter. Loan volumes were up 1% quarter-on-quarter and 4% year-on-year. Deposits excluding debt certificates were up 1% quarter-on-quarter and 1% year-on-year. Volume growth figures were calculated on an organic basis (excluding changes in the scope of consolidation and forex effects).
The insurance service result (insurance revenues before reinsurance - insurance service expenses before reinsurance + net result from reinsurance contracts held) amounted to 134 million euros (compared to 100 million euros and 110 million euros in the previous and year-earlier quarters, respectively) and breaks down into 94 million euros for non-life insurance and 41 million euros for life insurance. The non-life combined ratio for the first quarter of 2024 amounted to an excellent 85%, compared to 87% for full-year 2023. Non-life insurance sales increased by 9% year-on-year, while life insurance sales were up 12% on the level recorded in the previous quarter and by as much as 60% on the level recorded in the year-earlier quarter.
Net fee and commission income was up 2% and 7% on its level in the previous and year-earlier quarters, respectively. Fees for our asset management activities were up 5% quarter-on-quarter, while banking services-related fees were down 2% mainly due to seasonal effects. Year-on-year, fees for our asset management activities increased by 11% and fees for our banking activities decreased by 1%.
Trading & fair value income and insurance finance income and expense was down 15 million euros on the figure for the previous quarter and 79 million euros on the level recorded in the year-earlier quarter. Net other income was slightly above its normal run rate.
Operating expenses excluding bank and insurance taxes were down 9% on their level in the previous quarter and 1% on their year-earlier level. The first quarter of the year traditionally includes the bulk of the bank and insurance taxes for the full year (518 million euros in the first quarter of 2024). The cost/income ratio for the first quarter of 2024 came to 46%, compared to 49% for fullyear 2023. In that calculation, certain non-operating items have been excluded and bank and insurance taxes evenly spread throughout the year. Excluding all bank and insurance taxes, the cost/income ratio for the first quarter of 2024 amounted to 43%, the same level as for full-year 2023.
The quarter under review included a 16-million-euro net loan loss impairment charge, as opposed to a net release of 5 million euros in the previous quarter and 24 million euros in the year-earlier quarter. The credit cost ratio for the first quarter of 2024 amounted to 0.04%, compared to 0.00% for full-year 2023. Impairment on assets other than loans amounted to 0 million euros in the quarter under review, compared to 175 million euros in the previous quarter (including a 109-million-euro impairment on goodwill in the Czech Republic) and 1 million euros in the year-earlier quarter.
Our liquidity position remained strong, with an LCR of 162% and NSFR of 139%. Our capital base remained robust, with a fully loaded common equity ratio of 14.9% (not taking into account the extraordinary interim dividend of 0.70 euros per share, the ratio would have been 15.2%).

| (simplified; in millions of EUR) | 1Q2024 | 4Q2023 | 3Q2023 | 2Q2023 | 1Q2023 |
|---|---|---|---|---|---|
| Net interest income | 1 369 | 1 360 | 1 382 | 1 407 | 1 324 |
| Insurance revenues before reinsurance | 714 | 683 | 699 | 666 | 631 |
| Non-life | 598 | 584 | 587 | 567 | 543 |
| Life | 116 | 99 | 113 | 100 | 88 |
| Dividend income | 7 | 12 | 10 | 30 | 8 |
| Net result from financial instruments at fair value through P&L and Insurance finance income and expense 1 |
-55 | -40 | -8 | 33 | 24 |
| Net fee and commission income | 614 | 600 | 588 | 584 | 576 |
| Net other income | 58 | 60 | 44 | 54 | 498 |
| Total income | 2 708 | 2 674 | 2 715 | 2 775 | 3 060 |
| Operating expenses (excl. directly attributable from insurance) | -1 431 | -1 085 | -1 011 | -1 019 | -1 501 |
| Total operating expenses without bank and insurance taxes | -1 063 | -1 169 | -1 101 | -1 090 | -1 077 |
| Total bank and insurance taxes | -518 | -36 | -29 | -51 | -571 |
| Minus: operating expenses allocated to insurance service expenses | 150 | 120 | 119 | 123 | 147 |
| Insurance service expenses before reinsurance | -563 | -567 | -540 | -523 | -490 |
| Of which Insurance commission paid | -89 | -94 | -87 | -82 | -77 |
| Non-Life | -489 | -509 | -485 | -457 | -418 |
| Life | -73 | -58 | -55 | -66 | -72 |
| Net result from reinsurance contracts held | -18 | -16 | -22 | -22 | -30 |
| Impairment Of which: on financial assets at amortised cost and at fair value through other |
-16 | -170 | -63 | -8 | 26 |
| comprehensive income2 | -16 | 5 | -36 | 23 | 24 |
| Share in results of associated companies & joint ventures | 0 | 0 | 0 | -1 | -3 |
| Result before tax | 680 | 836 | 1 079 | 1 202 | 1 062 |
| Income tax expense | -175 | -159 | -203 | -236 | -180 |
| Result after tax | 506 | 677 | 877 | 966 | 882 |
| attributable to minority interests | |||||
| attributable to equity holders of the parent | 0 | 0 | 0 | 0 | 0 |
| Basic earnings per share (EUR) | 506 1.18 |
677 1.59 |
877 2.07 |
966 2.29 |
882 2.08 |
| Diluted earnings per share (EUR) | 1.18 | 1.59 | 2.07 | 2.29 | 2.08 |
| Key consolidated balance sheet figures, IFRS, | |||||
| KBC Group (in millions of EUR) | 31-03-2024 | 31-12-2023 | 30-09-2023 | 30-06-2023 | 31-03-2023 |
| Total assets | 359 477 | 346 921 | 358 453 | 368 077 | 347 355 |
| Loans & advances to customers | 183 722 | 183 613 | 181 821 | 182 005 | 179 520 |
| Securities (equity and debt instruments) | 73 561 | 73 696 | 72 765 | 71 839 | 70 291 |
| Deposits from customers (excl. debt certificates) | 216 271 | 216 423 | 214 203 | 224 710 | 219 342 |
| Insurance contract liabilities | 16 602 | 16 784 | 15 920 | 16 295 | 16 282 |
| Liabilities under investment contracts, insurance | 14 319 | 13 461 | 12 655 | 12 751 | 12 164 |
| Total equity | 23 917 | 24 260 | 23 865 | 22 853 | 23 141 |
| Selected ratios KBC Group (consolidated) | 1Q2024 | FY2023 | |||
| Return on equity3 Cost/income ratio, group |
9% | 16% | |||
| - excl. non-operating items and evenly spreading bank and insurance taxes throughout | |||||
| the year - excl. all bank and insurance taxes |
46% 43% |
49% 43% |
|||
| Combined ratio, non-life insurance | 85% | 87% | |||
| Common equity ratio (CET1), Basel III, Danish Compromise | |||||
| - fully loaded - transitional |
14.9% 15.1% |
15.2% 13.8% |
|||
| Credit cost ratio4 | 0.04% | 0.00% | |||
| Impaired loans ratio | |||||
| for loans more than 90 days past due | 2.1% 1.0% |
2.1% 1.0% |
|||
| Net stable funding ratio (NSFR) | 139% | 136% |
1 As of 2024, we have combined ' et result from financial instruments at fair value through P L' (also referred to as 'Trading & fair value income') and 'Insurance finance income and expense' in
one P&L line for the sake of simplification. The figures for past periods have been retroactively restated.
Also referred to as 'Loan loss impairment'.
3 14% in the first quarter of 2024 (and 15% for full-year 2023) when non-operating items are excluded and bank and insurance taxes evenly spread throughout the year.
4 A negative figure indicates a net impairment release (positively affecting results).
+1% quarter-on-quarter and -12% year-on-year
Net interest income amounted to 1 369 million euros in the quarter under review, up 1% quarter-on-quarter and 3% year-on-year. The quarter-on-quarter increase was due mainly to increasing reinvestment yields (which has a positive impact on the commercial transformation result), loan volume growth and slightly lower costs related to the minimum required reserves held with central banks. These items were partly offset by further shifts from current and savings accounts to customer term deposits at lower margins, continued pressure on loan margins in some core markets, lower interest income from inflation-linked bonds, lower dealing room interest income, a negative forex effect (depreciation of the Czech koruna and Hungarian forint) and fewer days in the quarter under review. The year-on-year increase was attributable primarily to the increase in the commercial transformation result, a higher ALM result, loan volume growth in all core countries and increased interest income from customer term deposits. These items were partly offset by pressure on lending margins in most core markets, lower interest income in Ireland (as a result of the sale of the portfolios there), lower dealing room interest income, lower interest income from inflation-linked bonds, the higher funding cost of participations, higher wholesale funding costs, a negative forex effect and higher costs related to the minimum required reserves held with central banks. Consequently, the net interest margin for the quarter under review amounted to 2.08%, up 9 basis points quarter-on-quarter and 4 basis points year-on-year. For guidance regarding the expected net interest income in 2024 and the years to come, please refer to the section entitled 'Our guidance'.
Customer loan volume was up 1% quarter-on-quarter and 4% year-on-year. Customer deposits excluding debt certificates were up 1% quarter-on-quarter and 1% year-on-year. When excluding volatile, low-margin short-term deposits at KBC Ban 's foreign branches (driven by short-term cash management opportunities), customer deposits were more or less stable quarter-on-quarter but down 2% year-on-year (still a consequence of the outflow of deposits caused by the issue of a 1-year State Note in Belgium in September 2023). In the growth figures above, the forex-related impact and the effects of changes in the scope of consolidation have been eliminated.
The insurance service result (insurance revenues before reinsurance – insurance service expenses before reinsurance + net result from reinsurance contracts held; the two latter items are not part of total income) amounted to 134 million euros and breaks down into 94 million euros for non-life insurance and 41 million euros for life insurance. The non-life insurance service result increased by 56% quarter-on-quarter, owing to a combination of higher insurance revenues and lower insurance service expenses. It was down 2% year-on-year, as higher insurance service expenses (due to the very low level of claims in the year-earlier quarter) more than offset the increased insurance revenues and better reinsurance result. The life insurance service result went up by 2% quarter-onquarter, as higher revenues were partly offset by increased insurance service expenses and a lower reinsurance result. It was 168% higher than the result for the year-earlier quarter, thanks almost entirely to higher insurance revenues.
The combined ratio of the non-life insurance activities amounted to an excellent 85% for the first quarter of 2024, compared to 87% for full-year 2023. Non-life insurance sales came to 730 million euros, up 9% year-on-year, with growth in all countries and classes, thanks to a combination of volume and tariff increases. Sales of life insurance products amounted to 765 million euros and were up 12% on the level recorded in the previous quarter, due to higher sales of unit-linked life insurance products (attributable to the launch of a new structured product and commercial campaigns in Belgium) which more than offset the lower sales of guaranteed-interest products (as the last quarter of the year traditionally includes higher volumes in tax-incentivised pension savings products in Belgium). Life insurance sales were up 60% on the (relatively low level in the) year-earlier quarter, due almost entirely to sales of unit-linked products more than doubling. Overall, the share of guaranteed-interest products and unit-linked products in our life insurance sales in the quarter under review amounted to 34% and 62%, respectively, with hybrid products (mainly in the Czech Republic) accounting for the remainder.
For guidance regarding the expected insurance revenues and combined ratio in 2024 and the years to come, please refer to the section entitled 'Our guidance'.
Net fee and commission income amounted to 614 million euros, up 2% and 7% on its level in the previous and year-earlier quarters, respectively. The quarter-on-quarter increase was attributable to 5% growth in fee income related to our asset management activities (due to higher management and entry fees) and seasonally higher distribution fees linked to non-life insurance, while fees related to banking activities fell by 2% mainly due to seasonal effects (lower level of payments fees, among other things). Year-on-year, fees for our asset management services increased by 11% (due entirely to higher management fees) and distribution fees linked to non-life insurance were up, while banking fees fell slightly by 1%. At the end of March 2024, our total assets under management amounted to 258 billion euros, up 5% quarter-on-quarter (+1 percentage point related to net inflows and +4 percentage points related to the quarter-on-quarter market performance). Assets under management were up 19% year-onyear, with net inflows accounting for +8 percentage points and market performance for +11 percentage points.
Trading & fair value income and insurance finance income and expense amounted to -55 million euros, down 15 million euros quarter-on-quarter and 79 million euros year-on-year. The quarter-on-quarter decrease was attributable mainly to the increased negative result from derivatives used for asset/liability management purposes, only partly offset by better dealing room results and the positive changes in market value adjustments (xVA). Year-on-year, the decrease was mostly related to the increased negative result from derivatives used for asset/liability management purposes.
The other remaining income items included dividend income of 7 million euros and net other income of 58 million euros. The latter was slightly above its 50-million-euro normal run rate (note that the significant decrease on the year-earlier figure was due to the fact that net other income in that quarter had included a positive, one-off impact of 405 million euros related to the sale of the Irish loan and deposit portfolios).
The quarter-on-quarter comparison of operating expenses is distorted by the fact that the bulk of the bank and insurance taxes for the full year is traditionally recorded in the first quarter of the year. In the first quarter of 2024, these taxes amounted to 518 million euros, compared to 36 million euros in the previous quarter and 571 million euros in the year-earlier quarter (the year-on-year decrease was due mainly to lower resolution fund contributions in the quarter under review, partly offset by additional national bank taxes in Belgium and Slovakia and an increased contribution to the deposit guarantee schemes).
Total operating expenses excluding bank and insurance taxes amounted to 1 063 million euros in the first quarter of 2024, down by 9% on their level in the previous quarter, owing mainly to lower ICT expenses, seasonally lower marketing and professional fee costs, decreased facility expenses, lower depreciation and a forex effect.
Operating expenses excluding bank and insurance taxes were down 1% on their year-earlier level, due to reduced costs for Ireland (given the sale of the Irish portfolios), lower depreciation and a forex effect, though this was largely offset by the negative impact of indexation, wage drift and higher ICT expenses, marketing costs and professional fees.
When certain non-operating items are excluded and bank and insurance taxes evenly spread throughout the year, the cost/income ratio for the first quarter of 2024 amounted to 46%, compared to 49% for full-year 2023. When excluding all bank and insurance taxes, the cost-income ratio improved to 43%, the same level as for full-year 2023.
For guidance regarding expected operating expenses and the cost/income ratio in 2024 and the years to come, please refer to the section entitled 'Our guidance'.
versus a 5-million-euro net release in the previous quarter and a 24-million-euro net release in the year-earlier quarter
In the quarter under review, we recorded a 16-million-euro net loan loss impairment charge, as opposed to a net release of 5 million euros in the previous quarter and a net release 24 million euros in the year-earlier quarter. The net impairment charge in the quarter under review included a charge of 43 million euros in respect of our loan book and a 27-million-euro release following the update of the reserve for geopolitical and macroeconomic uncertainties (on account of improving macroeconomic and microeconomic indicators). As a consequence, the outstanding reserve for geopolitical and macroeconomic uncertainties amounted to 223 million euros at the end of March 2024.
For the entire group, the credit cost ratio amounted to 0.04% for the first quarter of 2024 (0.10% excluding the changes in the reserve for geopolitical and macroeconomic uncertainties), compared to 0.00% for full-year 2023 (0.07% excluding the changes in the reserve for geopolitical and macroeconomic uncertainties). At the end of March 2024, 2.1% of our total loan book was classified as impaired ('Stage 3'), the same level as at year-end 2023. Impaired loans that are more than 90 days past due amounted to 1.0% of the loan book, again the same level as at year-end 2023.
For guidance regarding the expected credit cost ratio in and the years to come, please refer to the section entitled 'Our guidance'.
There were virtually no impairment charges on assets other than loans, as opposed to 175 million euros in the previous quarter and 1 million euros in the year-earlier quarter. The previous quarter had been impacted by a number of factors, including a 109-millioneuro impairment on good ill on building savings company ČSOBS (a subsidiary of ČSOB Ban ) follo ing the reduction in the building savings state subsidy in the Czech Republic and a 56 million euros in impairment charges on tangible and intangible assets (mainly software).
Belgium: at first sight, the net result (243 million euros) was down 49% quarter-on-quarter. However, the first quarter of the year traditionally includes the bulk of the bank and insurance taxes for the full year, hence distorting the quarter-on-quarter comparison. Excluding bank and insurance taxes, the net result was up 11% quarter-on-quarter, due primarily to the combined effect of slightly higher total income (thanks to higher insurance revenues and net fee and commission income), lower costs (excluding bank and insurance taxes), stable insurance service expenses and higher net impairment charges.
Czech Republic: at first sight, the net result (197 million euros) was up 93% quarter-on-quarter. Excluding bank and insurance taxes, forex effects (depreciation of the Czech koruna) and the one-off 109-million-euro impairment on goodwill on building savings company ČSOBS in the previous quarter, the net result was up 19% quarter-on-quarter. This was essentially attributable to a combination of higher total income (thanks mainly to higher net fee and commission income and trading & fair value income), lower costs (excluding bank and insurance taxes), lower insurance service expenses, and a net loan loss impairment charge (as opposed to a release in the previous quarter).
International Markets: the 146-million-euro net result breaks down as follows: 34 million euros in Slovakia, 50 million euros in Hungary and 63 million euros in Bulgaria. For the business unit as a whole, the net result was, at first sight, down 18% on the previous quarter's result. When excluding bank and insurance taxes, the result was up 45% quarter-on-quarter, due mainly to a combination of higher total income (thanks in part to higher net interest income, insurance revenues and trading & fair value income), lower costs (excluding bank and insurance taxes), higher insurance service expenses and a net impairment release (as opposed to a net charge in the previous quarter).
Group Centre: the net result (-80 million euros) was 2 million euros lower than the figure recorded in the previous quarter owing mainly to a combination of lower total income (due primarily to a decrease in trading & fair value income), lower costs and a net impairment release as opposed to a net charge in the previous quarter.
A full results table is provided in the 'Additional information' section of the quarterly report. A short analysis of the results per business unit is provided in the analyst presentation (available at www.kbc.com).
| Belgium | Czech Republic | International Markets | ||||
|---|---|---|---|---|---|---|
| Selected ratios by business unit | 1Q2024 | FY2023 | 1Q2024 | FY2023 | 1Q2024 | FY2023 |
| Cost/income ratio, group - excl. non-operational items and spreading bank and insurance taxes evenly throughout the year - excl. all bank and insurance taxes |
43% 41% |
46% 41% |
44% 42% |
47% 44% |
43% 35% |
45% 39% |
| Combined ratio, non-life insurance | 86% | 85% | 79% | 84% | 102%2 | 97%2 |
| Credit cost ratio1 | 0.11% | 0.06% | 0.04% | -0.18% | -0.25% | -0.06% |
| Impaired loans ratio | 2.1% | 2.0% | 1.4% | 1.4% | 1.7% | 1.8% |
1 A negative figure indicates a net impairment release (positively affecting results). See 'Details of ratios and terms' in the quarterly report. 2 Excluding windfall bank and insurance taxes in Hungary, the combined ratio amounted to 88% in the first quarter of 2024 and 94% for full-year 2023.
Common equity ratio of 14.9%, NSFR of 139%, LCR of 162%
At the end of March 2024, total equity came to 23.9 billion euros and comprised 22.2 billion euros in parent shareholders' equity and 1.75 billion euros in additional tier-1 instruments. Total equity was down 0.3 billion euros on its level at the end of 2023. This was accounted for by the combined effect of the inclusion of the profit for the first quarter of 2024 (+0.5 billion euros), the repurchase of own shares (-0.3 billion euros), more or less stable revaluation reserves, the repayment of additional tier-1 instruments (-0.5 billion euros) and a number of smaller items. We have provided details of these changes under 'Consolidated statement of changes in equity' in the 'Consolidated financial statements' section of the quarterly report.
The Annual General Meeting of Shareholders of 2 May 2024 approved a total gross dividend of 4.15 euros per share for financial year 2023, with an interim dividend of 1.0 euro per share already being paid in November 2023 and the remaining 3.15 euros per share being paid on 15 May 2024. In line with our announced capital deployment plan for full-year 2023, the Board of Directors has also decided to distribute the surplus capital above the fully loaded common equity ratio of 15% (approximately 280 million euros) in the form of an extraordinary interim dividend of 0.70 euros per share on 29 May 2024.
Our solvency position remained strong, as illustrated by a fully loaded common equity ratio (CET1) of 14.9% at 31 March 2024, compared to 15.2% at the end of 2023. Note that the ratio already includes the full impact of the ongoing 1.3-billion-euro share buyback programme and the extraordinary interim dividend of 0.70 euros per share. Not taking into account the extraordinary interim dividend, our common equity ratio would have been 15.2%. The solvency ratio for KBC Insurance under the Solvency II framework was 202% at the end of March 2024, compared to 206% at the end of 2023. We have provided more details and additional information on solvency under 'Solvency' in the 'Additional information' section of the quarterly report.
Our liquidity position remained excellent too, as reflected in an LCR ratio of 162% and an NSFR ratio of 139%, compared to 159% and 136%, respectively, at the end of 2023.
We have taken further important steps in our sustainability journey at KBC. We report on this journey and our sustainability performance transparently and consistently in our annual Sustainability Report. In this regard, we would refer the reader to the recently published Sustainability Report for 2023 on www.kbc.com, which provides a detailed overview of our ESG achievements.
We are particularly proud of some first-time achievements, such as reporting on the climate-related impact of part of our insurance underwriting portfolio for the first time, our first climate target for KBC Insurance's o n portfolio of corporate investments and the first extensive mandatory and voluntary reporting on our contribution to sustainable business aligned to the EU Taxonomy criteria.
KBC also successfully issued a new 8-year Green Bond in the amount of 750 million euros, the first issuance under our recently updated Green Bond Framework. The proceeds will be used for energy efficient buildings, renewable energy transactions and clean transportation. More than 100 different investors participated in this issuance which enables KBC to continue actively supporting the financing of environmentally sustainable economic activities.
As we are mainly active in banking, insurance and asset management, we are exposed to a number of typical risks for these financial sectors such as – but not limited to – credit default risk, counterparty credit risk, concentration risk, movements in interest rates, currency risk, market risk, liquidity and funding risk, insurance underwriting risk, changes in regulations, operational risk, customer litigation, competition from other and new players, as well as the economy in general. KBC closely monitors and manages each of these risks within a strict risk framework, but they may all have a negative impact on asset values or could generate additional charges beyond anticipated levels.
At present, a number of factors are considered to constitute the main challenges for the financial sector. These stem primarily from the mostly indirect, but lingering, impact of the war in Ukraine, including the delayed effects of the increase in energy and commodity prices and the supply-side shortages it triggered. This led to a surge in inflation, resulting in upward pressure on interest rates, lower growth prospects (or even fears of a recession) and some concerns about the creditworthiness of counterparties in the economic sectors most exposed. Geopolitical risks remain elevated, as evidenced by the escalating conflict in Gaza/Israel and the Middle East. A significant number of elections in 2024 across the world, including in the US, are adding to the geopolitical uncertainty. All these ris s affect global, but especially, European economies, including KBC's home mar ets. Regulatory and compliance ris s (including in relation to capital requirements, anti-money laundering regulations, GDPR and ESG/sustainability) also remain a dominant theme for the sector, as does enhanced consumer protection. Digitalisation (with technology, including AI, as a catalyst) presents both opportunities and threats to the business model of traditional financial institutions, while climate and environmental-related risks are becoming increasingly prevalent. Cyber risk has become one of the main threats during the past few years, not just for the financial sector, but for the economy as a whole. The war in Ukraine has triggered an increase in attacks worldwide. Finally, we have seen governments across Europe taking additional measures to support their budgets (via increased tax contributions from the financial sector) and their citizens and corporate sector (by, for instance, implementing interest rate caps on loans or by pushing for higher rates on savings accounts).
We provide risk management data in our annual reports, quarterly reports and dedicated risk reports, all of which are available at www.kbc.com.

After strong quarter-on-quarter growth of 0.8% in the fourth quarter (non-annualised), US growth slowed in the first quarter of 2024 to 0.4%. This still solid growth rate was mainly attributable to robust domestic demand, in particular private consumption growth, which was supported by persistently robust job creation and a remarkably low unemployment rate. Quarter-on-quarter growth is expected to slow further in the second quarter of 2024.
After the mild contraction in the fourth quarter of 2023 (-0.1%), euro area growth in the first quarter became positive again (0.3%). The manufacturing sector exhibited persistent weakness, while the service sector displayed tentative signs of recovery. From the second half of 2024 onwards, quarterly growth is expected to gradually increase, driven mainly by domestic consumption that benefits from falling inflation and the related increase in real wages.
Quarter-on-quarter growth in the first quarter in Belgium amounted to 0.3%, the same as in the previous quarter. Relatively strong domestic demand outweighed the negative contribution to growth of net exports. For the remainder of 2024, we expect growth to remain broadly in line with that of the euro area. Meanwhile, the Czech economy continued its recovery in the first quarter of 2024 (+0.5% quarter-on-quarter), a slightly faster rate than in the previous quarter. The stabilising manufacturing sector and private consumption growth supported by real wage growth thanks to lower inflation contributed to this performance. Based on our latest estimates, growth rates for the first quarter in our other Central European home markets also point to the recovery gaining traction (Bulgaria 0.5%, Slovakia 0.6% and Hungary 0.8%) with growth expected to gradually pick up more speed in the course of 2024.
The main risks to our short-term outlook for European growth include the global weakness of the manufacturing sector, particularly its effect on the German economy. Moreover, current geopolitical tensions pose risks in the form of more protectionism, supply chain disruptions and higher energy and commodity prices. In addition, political instability risks (various upcoming elections) and the impact of the government budget discussions for 2025 in the run-up to the re-activation of the EU Stability and Growth Pact might impact growth and risk premiums on sovereign debt in a number of European economies.
In the first quarter, the disinflationary trend in the euro area continued, hile the latest US inflation data pointed rather more to a pause in this process. Consequently, the ECB is still expected to go ahead ith the start of its rate cutting cycle in mid . The timing of the Fed's first rate cut and the overall number of cuts remains more uncertain and ill crucially hinge on ho sustainable the central ban assesses the further course of the disinflationary process to ards the inflation target. In the bac ground, the run do n of the Fed's and ECB's balance sheet ( uantitative Tightening) continues. oreover, the ECB ill end reinvesting maturing assets in its PEPP portfolio from on, after a transition period in the second half of .
As the end of the Fed's and ECB's monetary tightening cycle became apparent in the fourth quarter of , benchmar US and German bond yields fell sharply. Since early , ho ever, US and German bond yields have been steadily rising again as mar ets became increasingly a are that the easing cycle of short term interest rates in ould start later – and be more limited – than initially expected (especially in the US). This pushed up US and German year bond yields to about . % and . % respectively in the second half of April , ith the US German yield spread sharply idening to levels not seen since the start of the pandemic.
The sizeable growth differential, as well as the increased short-term and long-term interest rate differentials between the US and the euro area, led to a substantial strengthening of the US dollar against the euro. However, based on long-term fundamentals, we expect the US dollar to gradually weaken again in the course of 2024.
In early May, the Czech National Bank (CNB) lowered its policy rate by a further 50 basis points to 5.25%. Since the beginning of the year, the Czech koruna has depreciated against the euro. Nevertheless, it is likely to regain some ground against the euro in the remainder of 2024, thanks in part to the expected start of the ECB rate-cutting cycle in mid-2024.
Since the beginning of 2024, the National Bank of Hungary has cut its policy rate (base rate) four times, bringing it to 7.75%. Additional modest rate cuts are likely to follow. The exchange rate of the Hungarian forint against the euro depreciated during the first quarter of 2024. Driven by the structural inflation differential with the euro area, the forint is expected to continue depreciating in the course of 2024.
| Agenda | Extraordinary interim dividend: ex-coupon - 27 May 2024; record date - 28 May 2024; payment - 29 May 2024 2Q2024 results: 8 August 2024 3Q2024 results: 7 November 2024 Other events: www.kbc.com / Investor Relations / Financial calendar |
|---|---|
| More information on 1Q2024 |
Quarterly report: www.kbc.com / Investor Relations / Reports Company presentation: www.kbc.com / Investor Relations / Presentations |
| Information on IFRS 17 implementation |
Press release of 18 April 2023: www.kbc.com / Newsroom / Press release archive |
Consolidated financial statements according to IFRS
AC: Amortised Cost ALM: Asset Liability Management AT1: Additional tier-1 instruments BBA: Building block approach CSM: Contractual service margin ECL: Expected Credit Loss FA: Financial Assets FV: Fair Value FVO: Fair Value Option (designated upon initial recognition at Fair Value through Profit or Loss) FVOCI: Fair Value through Other Comprehensive Income FVPL: Fair Value through Profit or Loss GCA: Gross Carrying Amount HFT: Held For Trading IFIE: Insurance finance income and expense MFVPL: Mandatorily Measured at Fair Value through Profit or Loss (including HFT) OCI: Other Comprehensive Income OPEX: Operating expenses P&L: Income statement PAA: Premium allocation approach POCI: Purchased or Originated Credit Impaired Assets SPPI: Solely payments of principal and interest SRB: Single Resolution Board R/E: Retained Earnings UL: Unit linked VFA: Variable fee approach
Section reviewed by the Auditor
| (in millions of EUR) | Note | 1Q 2024 | 4Q 2023 | 1Q 2023 |
|---|---|---|---|---|
| Net interest income | 3.1 | 1 369 | 1 360 | 1 324 |
| Interest income | 3.1 | 5 123 | 5 391 | 4 305 |
| Interest expense | 3.1 | -3 754 | -4 031 | -2 982 |
| Insurance revenues before reinsurance | 3.6 | 714 | 683 | 631 |
| Non-life | 3.6 | 598 | 584 | 543 |
| Life | 3.6 | 116 | 99 | 88 |
| Dividend income | 7 | 12 | 8 | |
| Net result from financial instruments at fair value through profit or loss & Insurance finance income and expense (for insurance contracts issued) |
3.3 | - 55 | - 40 | 24 |
| Net result from financial instruments at fair value through profit or loss |
3.3 | 40 | 58 | 90 |
| Insurance finance income and expense (for insurance contracts issued) |
3.6 | - 95 | - 98 | - 66 |
| Net fee and commission income | 3.4 | 614 | 600 | 576 |
| Fee and commission income | 3.4 | 774 | 771 | 731 |
| Fee and commission expense | 3.4 | - 160 | - 171 | - 155 |
| Net other income | 3.5 | 58 | 60 | 498 |
| TOTAL INCOME | 2 708 | 2 674 | 3 060 | |
| Operating expenses (excluding Opex allocated to insurance service expenses) |
3.7 | -1 431 | -1 085 | -1 501 |
| Total Opex without bank and insurance tax | 3.7 | -1 063 | -1 169 | -1 077 |
| Total bank and insurance tax | 3.7 | - 518 | - 36 | - 571 |
| Minus: Opex allocated to insurance service expenses | 3.7 | 150 | 120 | 147 |
| Insurance service expenses before reinsurance | 3.6 | - 563 | - 567 | - 490 |
| Of which insurance commissions paid | 3.6 | - 89 | - 94 | - 77 |
| Non-life | 3.6 | - 489 | - 509 | - 418 |
| Of which Non-life - Claim related expenses | 3.6 | - 293 | - 328 | - 237 |
| Life | 3.6 | - 73 | - 58 | - 72 |
| 3.6 | - 18 | - 16 | - 30 | |
| Net result from reinsurance contracts held Impairment |
3.9 | - 16 | - 170 | 26 |
| on FA at amortised cost and at FVOCI | 3.9 | - 16 | 5 | 24 |
| on goodwill | 3.9 | 0 | - 109 | 0 |
| other | 3.9 | 0 | - 66 | 1 |
| 0 | 0 | - 3 | ||
| Share in results of associated companies and joint ventures RESULT BEFORE TAX |
680 | 836 | 1 062 | |
| Income tax expense | 3.11 | - 175 | - 159 | - 180 |
| Net post-tax result from discontinued operations | 0 | 0 | 0 | |
| RESULT AFTER TAX | 506 | 677 | 882 | |
| attributable to minority interests | 0 | 0 | 0 | |
| attributable to equity holders of the parent | 506 | 677 | 882 | |
| Earnings per share (in EUR) | ||||
| Ordinary | 1.18 | 1.59 | 2.08 | |
| Diluted | 1.18 | 1.59 | 2.08 |
In order to provide a more transparent view, we have combined the P&L lines 'Net result from financial instruments at fair value through profit or loss' and 'Insurance finance income and expense (for insurance contracts issued)'. In this way, the change in the fair value of the unit-linked liabilities, measured under IFRS 17 (Variable Fee Approach) (included in 'Insurance finance income and expense (for insurance contracts issued)') is offset by the change in the fair value of underlying unit-linked assets (included in 'Net result from financial instruments at fair value through profit or loss').
The impact of the most significant acquisitions and disposals in 2023 and 2024 is set out in note 6.6 further in this report.
| (in millions of EUR) | 1Q 2024 | 4Q 2023 | 1Q 2023 |
|---|---|---|---|
| RESULT AFTER TAX | 506 | 677 | 882 |
| Attributable to minority interests | 0 | 0 | 0 |
| Attributable to equity holders of the parent | 506 | 677 | 882 |
| OCI THAT MAY BE RECYCLED TO PROFIT OR LOSS | - 153 | 23 | 364 |
| Net change in revaluation reserve (FVOCI debt instruments) | - 99 | 583 | 108 |
| Net change in hedging reserve (cashflow hedges) | 4 | 113 | 68 |
| Net change in translation differences | - 168 | - 75 | 212 |
| Hedge of net investments in foreign operations | 41 | 36 | - 32 |
| Net insurance finance income and expense from (re)insurance contracts issued | 66 | - 639 | 6 |
| Net insurance finance income and expense from reinsurance contracts held | 1 | 6 | 3 |
| Net change in respect of associated companies and joint ventures | 0 | 0 | 0 |
| Other movements | 2 | 0 | 0 |
| OCI THAT WILL NOT BE RECYCLED TO PROFIT OR LOSS | 152 | 47 | 86 |
| Net change in revaluation reserve (FVOCI equity instruments) | 115 | 51 | 101 |
| Net change in defined benefit plans | 37 | - 5 | - 15 |
| Net change in own credit risk | 0 | 0 | 0 |
| Net change in respect of associated companies and joint ventures | 0 | 0 | 0 |
| TOTAL COMPREHENSIVE INCOME | 505 | 746 | 1 332 |
| Attributable to minority interests | 0 | 0 | 0 |
| Attributable to equity holders of the parent | 505 | 747 | 1 332 |
The largest movements in other comprehensive income (1Q 2024 and 1Q 2023):
| (in millions of EUR) | Note | 31-03-2024 | 31-12-2023 |
|---|---|---|---|
| ASSETS | |||
| Cash, cash balances with central banks and other demand deposits with credit institutions | 45 236 | 34 530 | |
| Financial assets | 4.0 | 307 408 | 306 047 |
| Amortised cost | 4.0 | 261 729 | 263 625 |
| Fair value through OCI | 4.0 | 19 415 | 18 587 |
| Fair value through profit or loss | 4.0 | 25 943 | 23 539 |
| of which held for trading | 4.0 | 9 813 | 8 327 |
| Hedging derivatives | 4.0 | 321 | 295 |
| Reinsurers' contract assets held | 87 | 64 | |
| Profit/loss on positions in portfolios hedged for interest rate risk | -2 507 | -2 402 | |
| Tax assets | 900 | 900 | |
| Current tax assets | 207 | 176 | |
| Deferred tax assets | 693 | 724 | |
| Non-current assets held for sale and disposal groups | 4 | 4 | |
| Investments in associated companies and joint ventures | 35 | 30 | |
| Property, equipment and investment property | 3 751 | 3 702 | |
| Goodwill and other intangible assets | 2 360 | 2 355 | |
| Other assets | 2 203 | 1 691 | |
| TOTAL ASSETS | 359 477 | 346 921 | |
| LIABILITIES AND EQUITY | |||
| Financial liabilities | 4.0 | 315 671 | 303 116 |
| Amortised cost | 4.0 | 293 482 | 280 874 |
| Fair value through profit or loss | 4.0 | 21 858 | 21 840 |
| of which held for trading | 4.0 | 6 145 | 7 050 |
| Hedging derivatives | 4.0 | 331 | 401 |
| Insurance contract liabilities | 5.6 | 16 602 | 16 784 |
| Non-life | 5.6 | 2 984 | 2 922 |
| Life | 5.6 | 13 618 | 13 862 |
| Profit/loss on positions in portfolios hedged for interest rate risk | - 506 | - 505 | |
| Tax liabilities | 514 | 472 | |
| Current tax liabilities | 130 | 99 | |
| Deferred tax liabilities | 384 | 373 | |
| Liabilities associated with disposal groups | 0 | 0 | |
| Provisions for risks and charges | 171 | 183 | |
| Other liabilities | 3 109 | 2 611 | |
| TOTAL LIABILITIES | 335 560 | 322 661 | |
| Total equity | 5.10 | 23 917 | 24 260 |
| Parent shareholders' equity | 5.10 | 22 166 | 22 010 |
| Additional tier-1 instruments included in equity | 5.10 | 1 750 | 2 250 |
| Minority interests | 0 | 0 | |
| TOTAL LIABILITIES AND EQUITY | 359 477 | 346 921 |
The increase of the total liabilities in 1Q 2024 can for the largest part be explained by higher time deposits from customers, higher repos, higher certificates of deposit and other issued bonds. This is partly offset by lower demand deposits from customers and repayment of matured part of the TLTRO III by 2.2 billion euros.
Total assets increase can for the largest part be explained by higher cash and cash balances with central banks.
| Issued | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| and paid up |
Total | Parent | AT1 instruments |
||||||
| share | Share | Treasury | Retained | revaluation | shareholders' | included in | Minority | Total | |
| (in millions of EUR) | capital | premium | shares | earnings | reserves | equity | equity | interests | equity |
| 31-03-2024 | |||||||||
| Balance at the beginning of the period | 1 461 | 5 548 | - 497 | 14 332 | 1 166 | 22 010 | 2 250 | 0 | 24 260 |
| Net result for the period | 0 | 0 | 0 | 506 | 0 | 506 | 0 | 0 | 506 |
| Other comprehensive income for the period | 0 | 0 | 0 | 2 | - 3 | - 1 | 0 | 0 | - 1 |
| Subtotal | 0 | 0 | 0 | 508 | - 3 | 505 | 0 | 0 | 505 |
| Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coupon on AT1 | 0 | 0 | 0 | - 31 | 0 | - 31 | 0 | 0 | - 31 |
| Issue/repurchase of AT1 included in equity | 0 | 0 | 0 | 0 | 0 | 0 | - 500 | 0 | - 500 |
| Transfer from revaluation reserves to retained earnings on realisation |
0 | 0 | 0 | 3 | - 3 | 0 | 0 | 0 | 0 |
| Purchase/sale of treasury shares | 0 | 0 | - 317 | 0 | 0 | - 317 | 0 | 0 | - 317 |
| Change in minorities interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total change | 0 | 0 | - 317 | 480 | - 7 | 157 | - 500 | 0 | - 343 |
| Balance at the end of the period | 1 461 | 5 548 | - 814 | 14 812 | 1 159 | 22 166 | 1 750 | 0 | 23 917 |
| 2023 | |||||||||
| Balance at the beginning of the period | 1 461 | 5 542 | 0 | 12 626 | 690 | 20 319 | 1 500 | 0 | 21 819 |
| Net result for the period | 0 | 0 | 0 | 3 402 | 0 | 3 402 | 0 | - 1 | 3 401 |
| Other comprehensive income for the period | 0 | 0 | 0 | - 1 | 497 | 495 | 0 | 0 | 495 |
| Subtotal | 0 | 0 | 0 | 3 400 | 497 | 3 897 | 0 | - 1 | 3 896 |
| Dividends | 0 | 0 | 0 | - 1 663 | 0 | - 1 663 | 0 | 0 | - 1 663 |
| Coupon on AT1 | 0 | 0 | 0 | - 50 | 0 | - 50 | 0 | 0 | - 50 |
| Issue/repurchase of AT1 included in equity | 0 | 0 | 0 | - 3 | 0 | - 3 | 750 | 0 | 747 |
| Capital increase | 0 | 6 | 0 | 0 | 0 | 7 | 0 | 0 | 7 |
| Transfer from revaluation reserves to retained earnings on realisation |
0 | 0 | 0 | 21 | - 21 | 0 | 0 | 0 | 0 |
| Purchase/sale of treasury shares | 0 | 0 | - 497 | 0 | 0 | - 497 | 0 | 0 | - 497 |
| Change in scope | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Change in minorities interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total change | 0 | 6 | - 497 | 1 705 | 476 | 1 691 | 750 | 0 | 2 441 |
| Balance at the end of the period | 1 461 | 5 548 | - 497 | 14 332 | 1 166 | 22 010 | 2 250 | 0 | 24 260 |
| 31-03-2023 | |||||||||
| Balance at the beginning of the period | 1 461 | 5 542 | 0 12 626 |
690 | 20 319 | 1 500 | 0 | 21 819 | |
| Net result for the period | 0 | 0 | 0 882 |
0 | 882 | 0 | 0 | 882 | |
| OCI for the period | 0 | 0 | 0 0 |
450 | 450 | 0 | 0 | 450 | |
| Subtotal | 0 | 0 | 0 882 |
450 | 1 332 | 0 | 0 | 1 332 | |
| Dividends | 0 | 0 | 0 0 |
0 | 0 | 0 | 0 | 0 | |
| Coupon on AT1 | 0 | 0 | 0 - 9 |
0 | - 9 | 0 | 0 | - 9 | |
| Capital increase | 0 | 0 | 0 0 |
0 | 0 | 0 | 0 | 0 | |
| Transfer from revaluation reserves to retained earnings on realisation |
0 | 0 | 0 13 |
- 13 | 0 | 0 | 0 | 0 | |
| Purchase/sale of treasury shares | 0 | 0 | 0 0 |
0 | 0 | 0 | 0 | 0 | |
| Change in minorities interests | 0 | 0 | 0 0 |
0 | 0 | 0 | 0 | 0 | |
| Total change | 0 | 0 | 0 886 |
437 | 1 323 | 0 | 0 | 1 323 | |
| Balance at the end of the period | 1 461 | 5 542 | 0 13 512 |
1 127 | 21 641 | 1 500 | 0 | 23 141 |
The Annual General Meeting on 2 May 2024 approved a final gross dividend of 4.15 euros per share related to the accounting year 2023, of which:
Additional interim dividend: see note 6.8 further in this report.
Call AT1: On 5 March 2024 KBC Group NV called the Additional Tier-1 Securities issued in 2019 for 500 million euros. For more information, see note 5.10 further in this report.
Treasury shares: within the framework of the share buyback programme of 1.3 billion euros announced on 10 August 2023, the total number of own shares bought by KBC related to the share buyback programme amounted to 13 843 378 at 31 March 2024. For more information: https://www.kbc.com/en/share-buy-back and Solvency section further in this report.
The 'Dividends' item in 2023 (1 663 million euros) includes the final dividend of 3.00 euros per share (1 252 million euros paid in May 2023) and the interim dividend of 1.00 euro per share (411 million euros paid in November 2023)
| Composition of the 'Total revaluation reserves' column in the previous table (in millions of EUR) | 31-03-2024 | 31-12-2023 | 31-03-2023 |
|---|---|---|---|
| Total | 1 159 | 1 166 | 1 127 |
| Revaluation reserve (FVOCI debt instruments) | - 696 | - 596 | - 987 |
| Revaluation reserve (FVOCI equity instruments) | 333 | 222 | 172 |
| Hedging reserve (cashflow hedges) | - 575 | - 579 | - 869 |
| Translation differences | - 409 | - 240 | 87 |
| Hedge of net investments in foreign operations | 168 | 127 | 43 |
| Remeasurement of defined benefit plans | 471 | 434 | 452 |
| Own credit risk through OCI | 0 | 0 | 0 |
| Insurance finance income and expense through OCI after reinsurance | 1 866 | 1 799 | 2 229 |
| (in millions of EUR) | Note | 1Q 2024 | 1Q 2023 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Result before tax | Cons. income stat. | 680 | 1 062 |
| Adjustments for non-cash items in profit & loss | 949 | -1 353 | |
| Changes in operating assets (excluding cash and cash equivalents) | -4 991 | - 390 | |
| Changes in operating liabilities (excluding cash and cash equivalents) | 14 756 | -12 440 | |
| Income taxes paid | - 136 | - 109 | |
| Net cash from or used in operating activities | 11 258 | -13 230 | |
| INVESTING ACTIVITIES | |||
| Purchase and proceeds of debt securities at amortised cost | 4.1 | 1 796 | -1 531 |
| Acquisition of a subsidiary or a business unit, net of cash acquired (including | |||
| increases in percentage interest held) | 0 | 0 | |
| Proceeds from the disposal of a subsidiary or business unit, net of cash disposed of (including decreases in percentage interest held) |
0 | 6 480 | |
| Purchase and proceeds from the sale of intangible fixed assets (excluding goodwill) | - 73 | - 79 | |
| Purchase and proceeds from the sale of property, plant and equipment (excluding | |||
| goodwill) | - 12 | - 50 | |
| Other | - 30 | 80 | |
| Net cash from or used in investing activities | 1 682 | 4 900 | |
| FINANCING ACTIVITIES | Cons. stat. of changes in | ||
| Purchase or sale of treasury shares | equity | - 317 | 0 |
| Issue or repayment of promissory notes and other debt securities | 4.1 | - 238 | 1 307 |
| Proceeds from or repayment of subordinated liabilities | 4.1 | 1 604 | 496 |
| Cons. stat. of changes in | |||
| Proceeds from the issuance of share capital | equity | 0 | 0 |
| Call of additional tier-1 instruments | Consolidated statement of changes in equity |
- 500 | 0 |
| Cons. stat. of changes in | |||
| Dividends paid | equity | 0 | 0 |
| Coupon additional Tier-1 instruments | Cons. stat. of changes in equity |
- 31 | - 9 |
| Net cash from or used in financing activities | 518 | 1 794 | |
| CHANGE IN CASH AND CASH EQUIVALENTS | |||
| Net increase or decrease in cash and cash equivalents | 13 458 | -6 535 | |
| Cash and cash equivalents at the beginning of the period | 53 961 | 67 481 | |
| Effects of exchange rate changes on opening cash and cash equivalents | - 606 | 766 | |
| Cash and cash equivalents at the end of the period | 66 812 | 61 712 | |
| COMPONENTS OF CASH AND CASH EQUIVALENTS | |||
| Cash and cash balances with central banks and other demand deposits with credit | Cons. | ||
| institutions | balance sheet | 45 236 | 38 729 |
| Term loans to banks at not more than three months (excl. reverse repos) | 4.1 | 956 | 1 213 |
| Reverse repos with credit institutions and investment firms at not more than three | |||
| months | 4.1 | 24 833 | 28 918 |
| Deposits from banks repayable on demand | 4.1 | -4 213 | -7 148 |
| Cash and cash equivalents belonging to disposal groups | 0 | 0 | |
| Total | 66 812 | 61 712 | |
| of which not available | 0 | 0 |
The net cash from operating activities in 1Q 2024 (+11 258 million euros) mainly includes an increase in time deposits and repos and the issuance of certificates of deposit, partly offset by lower demand deposits and repayment of most of the remaining outstanding amount borrowed under TLTRO III (-2.2 billion euros). The net cash from operating activities in 1Q 2023 (-13 230 million euros) mainly includes a decrease in demand deposits and lower repos, both to a large extent linked to short term cash management, and repayment of part of the amount borrowed under TLTRO III (-2.0 billion euros).
Net cash from (used in) investing activities in 1Q 2024 (+1 682 million euros) mainly includes net proceeds from debt securities at amortised cost (+ 1 796 million euros). Net cash from (used in) investing activities in 1Q 2023 (+4 900 million euros) is mainly explained by the cash proceeds from the sale of the Irish loan and deposit portfolios to Bank of Ireland Group, partly offset by additional investments in debt securities at amortised cost.
The net cash flow from financing activities in 1Q 2024 (+518 million euros) includes the issuance of new Tier-2 instruments (1 billion euros and 500 million British pounds) offset by the repayment of an Additional Tier-1 instrument (500 million euros; for more information see note 5.10) and the purchase of treasury shares (317 million euros). The net cash flow from financing activities in 1Q 2023 (+1 794 million euros) mainly includes newly issued Senior Holdco instruments (1 billion US dollars), new Tier-2 instrument (500 million euros) and net increase in covered bonds at KBC Bank (renewal (+1 billion euros) and a matured bond (-0.8 billion euros)).
The condensed interim financial statements of the KBC Group for the period ended 31 March 2024 have been prepared in accordance with IAS 34, 'Interim financial reporting'. The condensed interim financial statements should be read in conjunction with the annual financial statements for the year ended 31 December 2023, which have been prepared in accordance with the International Financial Reporting Standards as adopted for use in the European Union ('endorsed IFRS').
The following IFRS standards were issued but not yet effective in 2024. KBC will apply these standards when they become mandatory.
The IASB published several limited amendments to existing IFRSs and IFRICs. They will be applied when they become mandatory, but their impact is currently estimated to be negligible.
As of 1 January 2024, KBC has revised its multi-tier approach for the assessment of a significant increase in credit risk (please refer to Note 1.2: Summary of material accounting policies 'Significant increase in credit risk since initial recognition' in the annual accounts 2023). The indicators based on 12-months probability of default ('Internal rating' and 'Internal rating backstop') are replaced by an assessment based on lifetime probability of default and a watch list indicator. KBC applied the revised approach for the first time in 1Q 2024. This change in accounting estimate resulted in an ECL release of 17 million euros, included in Impairment on financial assets at amortised cost and at fair value through OCI (for more information see note 1.2).
Change to the presentation of the Consolidated income statement: see narrative below the Consolidated income statement.
A summary of the main accounting policies is provided in the group's annual accounts as at 31 December 2023. As mentioned in note 1.1 the paragraph regarding 'Significant increase in credit risk since initial recognition' has been updated as follows:
In accordance to the ECL model, a financial assets attracts life-time ECL once the credit risk has increased significantly since initial recognition; therefore the assessment of the significant increase in credit risk defines the staging of financial assets. The assessment of a significant increase in credit risk is a relative assessment based on the credit risk that was assigned at initial recognition. This is a multi-factor assessment, and, thus KBC has developed a multi-tier approach (MTA) for the bond portfolio on the one hand and for the loan portfolio on the other hand.
For the bond portfolio the MTA consists of three tiers:
If none of these triggers results in a migration to stage 2, then the bond remains in stage 1.
A financial asset is considered impaired (i.e. stage 3) as soon as it meets the definition of default.
The MTA is symmetrical, i.e. a credit that has migrated to stage 2 or 3 can return to stage 2 or 1 if the Tier that triggered the migration is not present in a subsequent reporting date.
For the loan portfolio KBC uses a five-tier approach. This MTA is a waterfall approach, i.e. if after assessing the first Tier, doesn't result in migrating to stage 2, then the second Tier is assessed and so on. At the end, if all Tiers are being assessed without triggering a migrations to stage 2, then the financial asset remains in stage 1.
A financial asset is considered impaired (i.e. stage 3) as soon as it meets the definition of default.
The MTA is symmetrical, i.e. a credit that has migrated to stage 2 or 3 can return to stage 2 or 1 if the Tier that triggered the migration is not met at the reporting date.
| Exchange rate at 31-03-2024 Average exchange rate in 1Q 2024 |
||||||
|---|---|---|---|---|---|---|
| Changes relative to 31-12-2023 | Changes relative to the average 1Q 2023 | |||||
| 1 EUR = … | Positive: appreciation relative to EUR | 1 EUR = … | Positive: appreciation relative to EUR | |||
| … currency | Negative: depreciation relative to EUR | … currency | Negative: depreciation relative to EUR | |||
| CZK | 25.305 | -2% | 25.090 | -6% | ||
| HUF | 395.26 | -3% | 389.14 | -1% |
For a description on the management structure and linked reporting presentation, reference is made to note 2.1 in the annual accounts 2023.
As a result of the Irish sale transaction in February 2023, the results of KBC Bank Ireland in 2024 (included in Group Centre) have become immaterial and are hence not disclosed anymore separately as of 2024. Regarding the impact of the sale of the Irish loan and deposit portfolios to Bank of Ireland Group, see further in note 6.6.
| Czech | International | |||||||
|---|---|---|---|---|---|---|---|---|
| Belgium | Republic | Markets | Of | |||||
| (in millions of EUR) | Business unit |
Business unit |
Business unit |
which: Hungary |
Slovakia | Bulgaria | Group Centre |
Total |
| 1Q 2024 | ||||||||
| Net interest income | 809 | 315 | 324 | 149 | 67 | 107 | - 79 | 1 369 |
| Insurance revenues before reinsurance | 443 | 138 | 130 | 52 | 26 | 53 | 4 | 714 |
| Non-life | 365 | 114 | 116 | 47 | 21 | 48 | 4 | 598 |
| Life | 78 | 24 | 15 | 5 | 5 | 5 | 0 | 116 |
| Dividend income | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 7 |
| Net result from financial instruments at fair value through profit or loss & Insurance finance income and expense (for insurance contracts issued) |
- 101 | 22 | 26 | 22 | 3 | 0 | - 1 | - 55 |
| Net fee and commission income | 409 | 84 | 122 | 63 | 21 | 37 | - 1 | 614 |
| Net other income | 54 | 5 | 6 | 3 | 3 | 0 | - 7 | 58 |
| TOTAL INCOME | 1 621 | 564 | 608 | 289 | 121 | 197 | - 85 | 2 708 |
| Operating expenses (excluding Opex allocated to insurance service expenses) |
- 841 | - 229 | - 326 | - 179 | - 64 | - 83 | - 36 | -1 431 |
| Total Opex without banking and insurance tax | - 606 | - 220 | - 200 | - 69 | - 62 | - 70 | - 37 | -1 063 |
| Total Banking and insurance tax | - 317 | - 35 | - 167 | - 137 | - 9 | - 21 | 1 | - 518 |
| Minus: Opex allocated to insurance service expenses |
82 | 26 | 41 | 27 | 7 | 8 | 1 | 150 |
| Insurance service expenses before reinsurance | - 340 | - 99 | - 125 | - 66 | - 24 | - 35 | 1 | - 563 |
| Of which insurance commissions paid | - 57 | - 17 | - 15 | - 2 | - 3 | - 9 | 0 | - 89 |
| Non-Life | - 289 | - 86 | - 116 | - 63 | - 21 | - 32 | 1 | - 489 |
| Of which Non-life - Claim related expenses | - 191 | - 49 | - 55 | - 25 | - 13 | - 17 | 2 | - 293 |
| Life | - 52 | - 13 | - 9 | - 3 | - 3 | - 3 | 0 | - 73 |
| Net result from reinsurance contracts held | - 24 | - 4 | 0 | 5 | - 1 | - 4 | 10 | - 18 |
| Impairment | - 37 | - 4 | 20 | 11 | 11 | - 2 | 4 | - 16 |
| of which on FA at AC and at fair value through OCI | - 37 | - 4 | 20 | 10 | 11 | - 2 | 4 | - 16 |
| Share in results of associated companies and joint ventures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| RESULT BEFORE TAX | 380 | 229 | 177 | 60 | 43 | 74 | - 105 | 680 |
| Income tax expense | - 137 | - 33 | - 30 | - 10 | - 9 | - 11 | 26 | - 175 |
| Net post-tax result from discontinued operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| RESULT AFTER TAX | 242 | 197 | 146 | 50 | 34 | 63 | - 80 | 506 |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | 243 | 197 | 146 | 50 | 34 | 63 | - 80 | 506 |
| Czech | International | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Belgium | Republic | Markets | Of | Of | |||||
| Business | Business | Business | which: | Group | which: | ||||
| (in millions of EUR) 1Q 2023 |
unit | unit | unit | Hungary | Slovakia | Bulgaria | Centre | Ireland | Total |
| Net interest income | 769 | 309 | 284 | 130 | 65 | 90 | - 39 | 24 | 1 324 |
| Insurance revenues before reinsurance | 385 | 132 | 111 | 46 | 23 | 43 | 2 | 0 | 631 |
| Non-life | 333 | 109 | 98 | 41 | 18 | 39 | 2 | 0 | 543 |
| Life | 52 | 23 | 13 | 5 | 4 | 4 | 0 | 0 | 88 |
| Dividend income | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8 |
| Net result from financial instruments at fair value through profit or loss & Insurance finance income and expense (for insurance contracts issued) |
- 29 | 22 | 13 | 12 | 0 | 1 | 18 | - 1 | 24 |
| Net fee and commission income | 382 | 80 | 116 | 58 | 20 | 37 | - 2 | 0 | 576 |
| Net other income | 87 | 2 | 5 | 1 | 2 | 2 | 404 | 404 | 498 |
| TOTAL INCOME | 1 603 | 544 | 530 | 247 | 110 | 172 | 384 | 428 | 3 060 |
| Operating expenses (excluding Opex allocated to insurance service expenses) |
- 849 | - 253 | - 305 | - 168 | - 58 | - 79 | - 95 | - 52 | -1 501 |
| Total Opex without banking and insurance tax | - 584 | - 220 | - 183 | - 60 | - 60 | - 62 | - 90 | - 47 | -1 077 |
| Total Banking and insurance tax | - 347 | - 60 | - 158 | - 130 | - 4 | - 24 | - 5 | - 5 | - 571 |
| Minus: Opex allocated to insurance service expenses |
82 | 28 | 36 | 23 | 7 | 7 | 1 | 0 | 147 |
| Insurance service expenses before reinsurance | - 304 | - 90 | - 96 | - 49 | - 19 | - 27 | - 1 | 0 | - 490 |
| Of which insurance commissions paid | - 51 | - 14 | - 12 | - 2 | - 2 | - 7 | 0 | 0 | - 77 |
| Non-Life | - 250 | - 79 | - 89 | - 46 | - 16 | - 27 | - 1 | 0 | - 418 |
| Of which Non-life - Claim related expenses | - 156 | - 43 | - 37 | - 14 | - 10 | - 14 | 0 | 0 | - 237 |
| Life | - 54 | - 11 | - 7 | - 3 | - 3 | - 1 | 0 | 0 | - 72 |
| Net result from reinsurance contracts held | - 21 | - 9 | - 5 | - 1 | - 1 | - 3 | 5 | 0 | - 30 |
| Impairment | 11 | 6 | 3 | 11 | - 1 | - 6 | 5 | 4 | 26 |
| of which on FA at AC and at fair value through OCI | 9 | 7 | 4 | 11 | - 1 | - 6 | 5 | 4 | 24 |
| Share in results of associated companies and joint ventures | - 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - 3 |
| RESULT BEFORE TAX | 438 | 198 | 128 | 40 | 31 | 57 | 299 | 379 | 1 062 |
| Income tax expense | - 139 | - 14 | - 20 | - 8 | - 6 | - 6 | - 7 | - 28 | - 180 |
| Net post-tax result from discontinued operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| RESULT AFTER TAX | 299 | 184 | 108 | 32 | 24 | 51 | 291 | 351 | 882 |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | 299 | 184 | 108 | 32 | 24 | 51 | 291 | 351 | 882 |
| (in millions of EUR) | 1Q 2024 | 4Q 2023 | 1Q 2023 |
|---|---|---|---|
| Total | 1 369 | 1 360 | 1 324 |
| Interest income | 5 123 | 5 391 | 4 305 |
| Interest income on financial instruments calculated using the effective interest rate method | |||
| Financial assets at AC | 2 484 | 2 688 | 2 357 |
| Financial assets at FVOCI | 103 | 123 | 77 |
| Hedging derivatives | 1 559 | 1 515 | 861 |
| Financial liabilities (negative interest) | 2 | 2 | 4 |
| Other | 501 | 475 | 483 |
| Interest income on other financial instruments | |||
| Financial assets MFVPL other than held for trading | 16 | 16 | 12 |
| Financial assets held for trading | 459 | 574 | 510 |
| Of which economic hedges | 415 | 531 | 474 |
| Other financial assets at FVPL | 0 | 0 | 0 |
| Interest expense | -3 754 | -4 031 | -2 982 |
| Interest expense on financial instruments calculated using the effective interest rate method | |||
| Financial liabilities at AC | -1 751 | -1 854 | -1 397 |
| Financial assets (negative interest) | - 1 | 0 | 0 |
| Hedging derivatives | -1 523 | -1 542 | - 912 |
| Other | - 1 | - 1 | - 1 |
| Interest expense on other financial instruments | |||
| Financial liabilities held for trading | - 460 | - 621 | - 658 |
| Of which economic hedges | - 446 | - 604 | - 648 |
| Other financial liabilities at FVPL | - 19 | - 18 | - 15 |
| Net interest expense relating to defined benefit plans | 1 | 4 | 1 |
The interest income on financial instruments calculated using the effective interest rate method – other, is mainly related to interest income on cash balances with central banks. These cash and cash balances are mainly funded with short term liabilities, such as certificates of deposits and repos. The interest expense related to this funding is part of interest expense on financial liabilities at AC. Net interest margin on this activity is narrow, resulting in limited net interest income.
Central Banks decided to increase the Minimum Reserve Requirements (MRR) and/or reduce the remuneration on these deposits. This results in a negative impact on net interest income of about 52 million euros in 1Q 2024, compared to 55 million euros in 4Q 2023 and 14 million euros in 1Q 2023.
| (in millions of EUR) | 1Q 2024 | 4Q 2023 | 1Q 2023 |
|---|---|---|---|
| Total | - 55 | - 40 | 24 |
| Breakdown by driver | |||
| Dealing room income | 102 | 78 | 94 |
| MTM ALM derivatives and other | - 102 | - 18 | - 24 |
| Market value adjustments (xVA) | 5 | - 41 | 4 |
| Result on investment backing UL contracts - under IFRS 17 & Insurance finance income and expense | - 60 | - 59 | - 50 |
In order to provide a more transparent view, we have combined the P&L lines 'Net result from financial instruments at fair value through profit or loss' and 'Insurance finance income and expense (for insurance contracts issued)'. In this way, the change in the fair value of the unit-linked liabilities, measured under IFRS 17 (Variable Fee Approach) (included in 'Insurance finance income and expense (for insurance contracts issued)') is offset by the change in the fair value of underlying unit-linked assets (included in 'Net result from financial instruments at fair value through profit or loss').
The result from financial instruments at fair value through profit or loss and Insurance finance income and expenses in 1Q 2024 is 15 million euros lower compared to 4Q 2023
The quarter-on-quarter evolution is explained as follows:
• More negative MTM ALM derivatives and other income in 1Q 2024 compared to 4Q 2023
Partly offset by
The result from financial instruments at fair value through profit or loss and Insurance finance income and expenses in 1Q 2024 is 79 million euros lower compared to 1Q 2023.
The year-to-date evolution is for a large part explained by:
Partly compensated by
| (in millions of EUR) | 1Q 2024 | 4Q 2023 | 1Q 2023 |
|---|---|---|---|
| Total | 614 | 600 | 576 |
| Fee and commission income | 774 | 771 | 731 |
| Fee and commission expense | - 160 | - 171 | - 155 |
| Breakdown by type | |||
| Asset Management Services | 338 | 323 | 304 |
| Fee and commission income | 353 | 338 | 319 |
| Fee and commission expense | - 15 | - 14 | - 15 |
| Banking Services | 261 | 265 | 262 |
| Fee and commission income | 404 | 421 | 397 |
| Fee and commission expense | - 143 | - 156 | - 134 |
| Other | 15 | 12 | 10 |
| Fee and commission income | 18 | 12 | 16 |
| Fee and commission expense | - 2 | 0 | - 6 |
• Asset Management Services include management fees, entry fees and distribution fees on mutual funds and unit-linked life products (under IFRS 9).
• Banking Services include credit- and guarantee related fees, payment service fees, network income, securities related fees, distribution fees banking products and other banking services.
• The distribution commissions paid regarding insurance contracts (life and non-life under IFRS 17) are presented in the income statement as Insurance Service Expenses (for more information, see note 3.6).
• The line Other includes distribution fees from third party insurance companies (not under IFRS 17) and platformication revenues.
| (in millions of EUR) | 1Q 2024 | 4Q 2023 | 1Q 2023 |
|---|---|---|---|
| Total | 58 | 60 | 498 |
| of which gains or losses on | |||
| Sale of financial assets measured at amortised cost | - 10 | - 4 | - 4 |
| Sale of debt instruments at FVOCI | 0 | - 1 | 1 |
| Repurchase of financial liabilities measured at amortised cost | 0 | 0 | 0 |
| of which other, including: | 68 | 65 | 502 |
| Income from operational leasing activities | 28 | 19 | 25 |
| Income from VAB Group | 13 | 10 | 10 |
| Legacy legal cases | 0 | 0 | - 2 |
| Gain on sale of KBC Bank Ireland's loan and deposit portfolios | 0 | 0 | 405 |
| Gain on sale of a participation in Belgium | 0 | 18 | 0 |
| Recovery of Belgian bank and insurance tax from 2016 (incl. moratorium interest) | 0 | 0 | 48 |
In 1Q 2024:
• no special items
In 4Q 2023:
• Realised gain on sale of a participation under equity method in Belgium (+18 million euros)
In 1Q 2023:
The table below includes intragroup transactions between bank and insurance entities (the results for insurance contracts concluded between the group's bank and insurance entities, interest that insurance companies receive on their deposits with bank entities, distribution commissions intra-group…) in order to give a more accurate view of the profitability of the insurance business.
| of which life | |||||
|---|---|---|---|---|---|
| direct | |||||
| (in millions of EUR) | Life | participating (VFA) |
Non-life | Non technical |
Total |
| 1Q 2024 | |||||
| Insurance service result | 43 | 3 | 110 | — | 153 |
| Insurance revenues before reinsurance | 116 | 6 | 600 | — | 717 |
| Insurance service expenses | - 73 | - 3 | - 490 | — | - 564 |
| Of which Non-life - Claim related expenses | — | — | - 293 | — | - 293 |
| Investment result and insurance finance income and expenses | 36 | 0 | 7 | — | 43 |
| Investment result | 121 | 36 | 17 | 0 | 138 |
| Net interest income | 80 | 0 | 15 | 0 | 95 |
| Dividend income | 4 | 0 | 1 | 0 | 5 |
| Net result from financial instruments at fair value through P&L | 37 | 35 | 0 | 0 | 37 |
| Net other income | 1 | 0 | 0 | 0 | 1 |
| Impairment | 1 | 0 | 0 | 0 | 1 |
| Total insurance finance income and expenses before reinsurance |
- 85 | - 36 | - 10 | — | - 95 |
| Interest accretion | - 49 | — | - 11 | — | - 60 |
| Effect of changes in financial assumptions and foreign exchange differences |
0 | 0 | 0 | — | 0 |
| Changes in fair value re. liabilities of IFRS 17 unit linked contracts | - 36 | - 36 | — | — | - 36 |
| Net insurance and investment result before reinsurance | 80 | 3 | 117 | 0 | 196 |
| Net result from reinsurance contracts held | - 3 | — | - 15 | — | - 18 |
| Premiums paid to the reinsurer | - 10 | — | - 26 | — | - 37 |
| Commissions received | 1 | — | 3 | — | 4 |
| Amounts recoverable from reinsurer | 6 | — | 9 | — | 16 |
| Total (ceded) reinsurance finance income and expense | 0 | — | - 1 | — | - 1 |
| Net insurance and investment result after reinsurance | 77 | 3 | 102 | 0 | 178 |
| Non-directly attributable income and expenses | 4 | 0 | - 13 | 6 | - 3 |
| Net fee and commission income | 18 | 0 | 0 | 10 | 28 |
| Net other income | 0 | — | — | 18 | 18 |
| Operating expenses (incl. banking and insurance tax) | - 15 | 0 | - 12 | - 22 | - 49 |
| Impairment - Other | 0 | 0 | 0 | 0 | 0 |
| Share in results of assoc. comp & joint-ventures | — | — | — | 0 | 0 |
| Income tax | — | — | — | - 42 | - 42 |
| Result after tax | 80 | 3 | 89 | - 36 | 133 |
| Attributable to minority interest | — | — | — | — | — |
| Attributable to equity holders of the parent | — | — | — | — | 133 |
| of which life direct participating |
Non | ||||
|---|---|---|---|---|---|
| (in millions of EUR) | Life | (VFA) | Non-life | technical | Total |
| 1Q 2023 | |||||
| Insurance service result | 16 | 4 | 128 | — | 144 |
| Insurance revenues before reinsurance | 88 | 6 | 547 | — | 635 |
| Insurance service expenses | - 72 | - 2 | - 418 | — | - 490 |
| Of which Non-life - Claim related expenses | — | — | - 237 | — | - 237 |
| Investment result and insurance finance income and expenses | 37 | 0 | 11 | — | 52 |
| Investment result on assets | 98 | 16 | 16 | 3 | 118 |
| Net interest income | 75 | 0 | 15 | 2 | 92 |
| Dividend income | 4 | 0 | 1 | 0 | 5 |
| Net result from financial instruments at fair value through P&L | 17 | 16 | 0 | 0 | 17 |
| Net other income | 3 | 0 | 0 | 1 | 4 |
| Impairment | 0 | 0 | 0 | 0 | 0 |
| Total insurance finance income and expenses before reinsurance |
- 61 | - 16 | - 5 | — | - 66 |
| Interest accretion | - 45 | — | - 5 | — | - 50 |
| Effect of changes in financial assumptions and foreign exchange differences |
0 | 0 | 0 | — | 0 |
| Changes in fair value re. liabilities of IFRS 17 unit linked contracts | - 16 | - 16 | — | — | - 16 |
| Net insurance and investment result before reinsurance | 53 | 4 | 140 | 3 | 196 |
| Net result from reinsurance contracts held | - 1 | — | - 29 | — | - 30 |
| Premiums paid to the reinsurer | - 9 | — | - 23 | — | - 32 |
| Commissions received | 0 | — | 2 | — | 2 |
| Amounts recoverable from reinsurer | 8 | — | - 8 | — | 1 |
| Total (ceded) reinsurance finance income and expenses | 0 | — | - 1 | — | - 1 |
| Net insurance and investment result after reinsurance | 52 | 4 | 110 | 3 | 166 |
| Non-directly attributable income and expenses | 1 | 0 | - 10 | 6 | - 3 |
| Net fee and commission income | 15 | 0 | 0 | 9 | 24 |
| Net other income | 0 | — | — | 16 | 16 |
| Operating expenses (incl. banking and insurance tax) | - 14 | 0 | - 10 | - 19 | - 43 |
| Impairment - Other | 0 | 0 | 0 | 0 | 0 |
| Share in results of assoc. comp & joint-ventures | — | — | — | 0 | 0 |
| Income tax | — | — | — | - 37 | - 37 |
| Result after tax | 54 | 4 | 100 | - 29 | 125 |
| Attributable to minority interest | — | — | — | — | 0 |
| Attributable to equity holders of the parent | — | — | — | — | 125 |
The non-technical account includes also results of non-insurance companies such as VAB group and ADD.
The column 'of which life direct participating (VFA)' relates to results of long-term unit-linked contracts in Central and Eastern Europe. Total insurance finance income and expenses before reinsurance includes changes in fair value of underlying assets of contracts measured under VFA, which represents the fair value movement of unit-linked liabilities, valued under IFRS 17 (variable fee approach), with the offsetting impact in fair value movement of underlying unit-linked assets in net result from financial instruments at fair value through profit or loss (see also note 3.3, result on investment backing UL contracts - under IFRS 17).
The total Operating expenses by nature include also Opex allocated to insurance service expenses (directly attributable from insurance) in order to provide a comprehensive overview of the total cost evolution.
| (in millions of EUR) | 1Q 2024 | 4Q 2023 | 1Q 2023 |
|---|---|---|---|
| Total Operating expenses by nature | -1 582 | -1 205 | -1 648 |
| Staff Expenses | - 663 | - 667 | - 663 |
| General administrative expenses | - 826 | - 443 | - 884 |
| ICT Expenses | - 144 | - 167 | - 142 |
| Facility Expenses | - 60 | - 72 | - 64 |
| Marketing & communication expenses | - 19 | - 40 | - 18 |
| Professional fees | - 32 | - 45 | - 29 |
| Bank and insurance tax | - 518 | - 36 | - 571 |
| Other | - 52 | - 82 | - 60 |
| Depreciation and amortisation of fixed assets | - 92 | - 96 | - 100 |
The operating expenses for 1Q 2024 include 518 million euros related to bank and insurance levies (36 million euros in 4Q 2023; 571 million euros in 1Q 2023). Application of IFRIC 21 (Levies) has as a consequence that the majority of the levies are taken upfront in expense of the first quarter of the year.
1Q 2024 includes 71 million euros extraordinary sectoral tax in K&H Hungary, compared to 79 million euros in 1Q 2023.
The Belgian government decided in 3Q 2023 to increase the national bank taxes by: (1) higher bank taxes for deposits on the balance sheet above 50 billion EUR (impact amounts to -28 million euros in 1Q 2024) and (2) abolishment of the income tax deductibility of the banking taxes (see note 3.11 further in this report).
Additionally, a further increase of the bank taxes is driven by an increase of the contribution to the Deposit Guarantee Scheme of -34 million euros in 1Q 2024 (of which -28 million euros in Belgium).
After reaching the target level of 1% of the covered deposits for the Single Resolution Fund in 2023, no annual contribution will be collected in 2024 in the eurozone countries (in 1Q 2024 still -27 million euros related to contribution from non-eurozone countries). In 1Q 2023, the total contribution to the Single Resolution Fund amounted to -148 million euros.
| (in millions of EUR) | 1Q 2024 | 4Q 2023 | 1Q 2023 |
|---|---|---|---|
| Total | - 16 | - 170 | 26 |
| Impairment on financial assets at AC and at FVOCI | - 16 | 5 | 24 |
| By IFRS category | |||
| Impairment on financial assets at AC | - 16 | 7 | 24 |
| Impairment on financial assets at FVOCI | 0 | - 2 | 0 |
| By product | |||
| Loans and advances | - 16 | 14 | 5 |
| Debt securities | - 1 | - 4 | 0 |
| Off-balance-sheet commitments and financial guarantees | 0 | - 4 | 19 |
| By type | |||
| Stage 1 (12-month ECL) | - 36 | 4 | 1 |
| Stage 2 (lifetime ECL) | 95 | 60 | 4 |
| Stage 3 (non-performing; lifetime ECL) | - 53 | - 57 | 20 |
| Purchased or originated credit impaired assets | - 22 | - 2 | - 1 |
| By division/country | |||
| Belgium | - 37 | - 10 | 9 |
| Czech Republic | - 4 | 14 | 7 |
| International Markets | 20 | 1 | 4 |
| Slovakia | 11 | 2 | - 1 |
| Hungary | 10 | - 1 | 11 |
| Bulgaria | - 2 | - 1 | - 6 |
| Group Centre | 4 | 0 | 5 |
| Impairment on goodwill | 0 | - 109 | 0 |
| Impairment on other | 0 | - 66 | 1 |
| Intangible fixed assets (other than goodwill) | 0 | - 50 | 0 |
| Property, plant and equipment (including investment property) | 0 | - 5 | 2 |
| Associated companies and joint ventures | 0 | 0 | 0 |
| Other | 0 | - 10 | 0 |
The impairment on financial assets at AC and at FVOCI in 1Q 2024 includes:
Impairment on goodwill in 4Q 2023: ČSOB Stavební spořitelna (or ČSOB Stavební, subsidiary of ČSOB Czech Republic) was impacted by the reduction of the building saving state subsidy in the Czech Republic in 2023, having a substantial negative impact to its future projected earnings. This has led to an impairment of 109 million euros on the total outstanding goodwill of 175 million euros (based on the exchange rate of 31 December 2023).
The impairments on property and equipment and intangible assets in 4Q 2023 (-55 million euros) mainly relate to impairments on software in all countries except Slovakia.
The impairment on other (Other) in 4Q 2023 of -10 million euros concern modification losses, related to the latest extension of the interest cap regulation in Hungary until 1 July 2024.
In 2023, income tax expense was impacted by the non-tax deductibility as of 2023 (for 80%) of the Belgian national banking and insurance taxes, increasing the income tax expenses with about 36 million euros (impact fully in 1Q 2023). The Belgian government decided to abolish the remainder of the tax deductibility of the banking taxes (versus the current 20%) as of 2024, increasing the income tax expenses in 1Q 2024 with about 11 million euros.
Top-up tax: On 14 December 2023, Belgium, where ultimate parent company KBC Group NV has its registered office, laid down the Pillar Two global minimum tax in statute and declared that it would take effect on 1 January 2024. Under these rules, KBC is required to pay top-up tax (in Belgium or abroad) on the profits of its subsidiaries and permanent establishments, which are taxed at an effective tax rate of less than 15%. Based on the 1Q 2024 results, the additional top-up tax amounts to roughly 6 million euros. The group has applied the temporary exception issued by the IASB in May 2023 relating to the accounting requirements for deferred taxes in IAS 12. The group will continue to monitor the effect of the Pillar Two legislation on its future financial performance.
Based on the approval received from the Irish Department of Finance on 13 September 2023, to transfer the remaining positions of KBC Bank Ireland to KBC Bank Dublin branch, which was implemented in December 2023, the main hurdles to start the legal liquidation process of KBC Bank Ireland have been taken. On 30 April 2024, KBC Bank Ireland returned its banking license to the Central Bank of Ireland. The aim is to close this liquidation process in the fourth quarter of 2024. The closing of the liquidation process can give rise to a tax deductible loss in KBC Bank NV in 2024 for which no deferred tax assets are yet recognized, as we consider this as a contingent asset at this moment subject to official authorization of the Irish tax authorities to liquidate KBC Bank Ireland (confirmation of no outstanding debt). This could lead to a tax benefit in P&L of 0.3 billion euros in the fourth quarter of 2024.
| Meas | |||||||
|---|---|---|---|---|---|---|---|
| ured at | |||||||
| fair value | Mandatorily | ||||||
| through | measured at | ||||||
| Meas ured at |
other compre |
fair value through profit |
Desig | ||||
| amor | hensive | or loss | Held for | nated at | Hedging | ||
| tised | income | (MFVPL) excl. | trading | fair value | deriva | ||
| (in millions of EUR) | cost (AC) | (FVOCI) | HFT | (HFT) | (FVO) | tives | Total |
| FINANCIAL ASSETS, 31-03-2024 | |||||||
| Loans and advances to credit institutions and investment firms (excl. reverse repos) |
2 523 | 0 | 0 | 1 | 0 | 0 | 2 523 |
| of which repayable on demand and term loans at not more than three months |
956 | ||||||
| Loans and advances to customers (excl. reverse repos) | 182 873 | 0 | 849 | 0 | 0 | 0 | 183 722 |
| Trade receivables | 2 590 | 0 | 0 | 0 | 0 | 0 | 2 590 |
| Consumer credit | 6 643 | 0 | 594 | 0 | 0 | 0 | 7 237 |
| Mortgage loans | 75 057 | 0 | 254 | 0 | 0 | 0 | 75 311 |
| Term loans | 85 330 | 0 | 0 | 0 | 0 | 0 | 85 330 |
| Finance lease | 7 438 | 0 | 0 | 0 | 0 | 0 | 7 438 |
| Current account advances | 5 095 | 0 | 0 | 0 | 0 | 0 | 5 095 |
| Other | 721 | 0 | 0 | 0 | 0 | 0 | 721 |
| Reverse repos | 25 017 | 0 | 0 | 805 | 0 | 0 | 25 822 |
| with credit institutions and investment firms | 24 912 | 0 | 0 | 805 | 0 | 0 | 25 717 |
| with customers | 105 | 0 | 0 | 0 | 0 | 0 | 105 |
| Equity instruments | 0 | 1 710 | 50 | 510 | 0 | 0 | 2 269 |
| Investment contracts (insurance) | 0 | 0 | 15 218 | 0 | 0 | 0 | 15 218 |
| Debt securities issued by | 49 212 | 17 705 | 14 | 4 361 | 0 | 0 | 71 292 |
| Public bodies | 41 390 | 13 637 | 0 | 4 176 | 0 | 0 | 59 202 |
| Credit institutions and investment firms | 5 528 | 2 151 | 0 | 20 | 0 | 0 | 7 699 |
| Corporates | 2 295 | 1 918 | 14 | 165 | 0 | 0 | 4 391 |
| Derivatives | 0 | 0 | 0 | 4 137 | 0 | 321 | 4 458 |
| Other | 2 103 | 0 | 0 | 0 | 0 | 0 | 2 103 |
| Total | 261 729 | 19 415 | 16 130 | 9 813 | 0 | 321 | 307 408 |
| FINANCIAL ASSETS, 31-12-2023 | |||||||
| Loans and advances to credit institutions and investment firms (excl. reverse repos) |
2 779 | 0 | 0 | 1 | 0 | 0 | 2 779 |
| of which repayable on demand and term loans at not more than three months |
222 | ||||||
| Loans and advances to customers (excl. reverse repos) | 182 777 | 0 | 836 | 0 | 0 | 0 | 183 613 |
| Trade receivables | 2 680 | 0 | 0 | 0 | 0 | 0 | 2 680 |
| Consumer credit | 6 604 | 0 | 608 | 0 | 0 | 0 | 7 211 |
| Mortgage loans | 75 254 | 0 | 228 | 0 | 0 | 0 | 75 482 |
| Term loans | 85 694 | 0 | 0 | 0 | 0 | 0 | 85 694 |
| Finance lease | 7 197 | 0 | 0 | 0 | 0 | 0 | 7 197 |
| Current account advances | 4 626 | 0 | 0 | 0 | 0 | 0 | 4 626 |
| Other | 723 | 0 | 0 | 0 | 0 | 0 | 723 |
| Reverse repos | 25 501 | 0 | 0 | 0 | 0 | 0 | 25 501 |
| with credit institutions and investment firms | 25 356 | 0 | 0 | 0 | 0 | 0 | 25 356 |
| with customers | 144 | 0 | 0 | 0 | 0 | 0 | 144 |
| Equity instruments | 0 | 1 695 | 14 | 570 | 0 | 0 | 2 279 |
| Investment contracts (insurance) | 0 | 0 | 14 348 | 0 | 0 | 0 | 14 348 |
| Debt securities issued by | 51 372 | 16 892 | 14 | 3 138 | 0 | 0 | 71 417 |
| Public bodies | 43 337 | 13 206 | 0 | 2 966 | 0 | 0 | 59 509 |
| Credit institutions and investment firms | 5 658 | 1 826 | 0 | 12 | 0 | 0 | 7 496 |
| Corporates | 2 377 | 1 861 | 14 | 160 | 0 | 0 | 4 412 |
| Derivatives | 0 | 0 | 0 | 4 618 | 0 | 295 | 4 914 |
| Other | 1 196 | 0 | 0 | 0 | 0 | 0 | 1 196 |
| Total | 263 625 | 18 587 | 15 212 | 8 327 | 0 | 295 | 306 047 |
| Measured at | Held for | ||||
|---|---|---|---|---|---|
| amortised cost | trading | Designated at fair | Hedging | ||
| (in millions of EUR) | (AC) | (HFT) | value (FVO) | derivatives | Total |
| FINANCIAL LIABILITIES, 31-03-2024 Deposits from credit institutions and investment firms |
|||||
| (excl. repos) | 13 798 | 0 | 0 | 0 | 13 798 |
| of which repayable on demand | 4 213 | ||||
| Deposits from customers and debt securities (excl. repos) |
262 227 | 50 | 1 423 | 0 | 263 700 |
| Demand deposits | 97 607 | 0 | 0 | 0 | 97 607 |
| Time deposits | 48 226 | 50 | 268 | 0 | 48 544 |
| Savings accounts | 70 120 | 0 | 0 | 0 | 70 120 |
| Subtotal deposits of clients, excl. repos | 215 953 | 50 | 268 | 0 | 216 271 |
| Certificates of deposit | 19 353 | 0 | 7 | 0 | 19 359 |
| Savings certificates | 42 | 0 | 0 | 0 | 42 |
| Non-convertible bonds | 22 583 | 0 | 1 036 | 0 | 23 619 |
| Non-convertible subordinated liabilities | 4 297 | 0 | 111 | 0 | 4 408 |
| Repos | 13 010 | 171 | 0 | 0 | 13 181 |
| with credit institutions and investment firms | 8 134 | 171 | 0 | 0 | 8 305 |
| with customers | 4 876 | 0 | 0 | 0 | 4 876 |
| Liabilities under investment contracts | 29 | 0 | 14 290 | 0 | 14 319 |
| Derivatives | 0 | 4 886 | 0 | 331 | 5 217 |
| Short positions | 0 | 1 037 | 0 | 0 | 1 037 |
| In equity instruments | 0 | 11 | 0 | 0 | 11 |
| In debt securities | 0 | 1 026 | 0 | 0 | 1 026 |
| Other | 4 417 | 1 | 0 | 0 | 4 418 |
| Total | 293 482 | 6 145 | 15 713 | 331 | 315 671 |
| FINANCIAL LIABILITIES, 31-12-2023 | |||||
| Deposits from credit institutions and investment firms (excl. repos) |
15 013 | 0 | 0 | 0 | 15 013 |
| of which repayable on demand | 6 136 | ||||
| Deposits from customers and debt securities (excl. repos) |
258 051 | 81 | 1 359 | 0 | 259 491 |
| Demand deposits | 107 568 | 0 | 0 | 0 | 107 568 |
| Time deposits | 37 770 | 81 | 194 | 0 | 38 044 |
| Savings accounts | 70 810 | 0 | 0 | 0 | 70 810 |
| Subtotal deposits of clients, excl. repos | 216 148 | 81 | 194 | 0 | 216 423 |
| Certificates of deposit | 16 840 | 0 | 6 | 0 | 16 846 |
| Savings certificates | 79 | 0 | 0 | 0 | 79 |
| Non-convertible bonds | 22 294 | 0 | 1 045 | 0 | 23 339 |
| Non-convertible subordinated liabilities | 2 690 | 0 | 114 | 0 | 2 804 |
| Repos | 5 235 | 40 | 0 | 0 | 5 275 |
| with credit institutions and investment firms | 3 259 | 40 | 0 | 0 | 3 298 |
| with customers | 1 976 | 0 | 0 | 0 | 1 976 |
| Liabilities under investment contracts | 29 | 0 | 13 432 | 0 | 13 461 |
| Derivatives | 0 | 5 501 | 0 | 401 | 5 902 |
| Short positions | 0 | 1 428 | 0 | 0 | 1 428 |
| In equity instruments | 0 | 6 | 0 | 0 | 6 |
| In debt securities | 0 | 1 421 | 0 | 0 | 1 421 |
| Other | 2 546 | 0 | 0 | 0 | 2 547 |
| Total | 280 874 | 7 050 | 14 791 | 401 | 303 116 |
Deposits from credit institutions and investment firms: includes funding from the ECB's TLTRO programme. In 2023 an amount of 12.9 billion euros was repaid (of which 10.9 billion euros at maturity in 2Q 2023 and 2 billion euros in 1Q 2023). In 1Q 2024 an amount of 2.2 billion euros matured, leaving 0.4 billion euros outstanding.
In 1Q 2024, there was also a substantial shift from demand to time deposits for about 10 billion euros, for the largest part situated in the foreign branches of KBC Bank NV (volatile corporate client deposits) and to a lesser extent following the market trend to shift from non-maturity to maturity funding.
| (in millions of EUR) | Carrying value before impairment |
Impairment | Carrying value after impairment |
|---|---|---|---|
| 31-03-2024 | |||
| FINANCIAL ASSETS AT AMORTISED COST | |||
| Loans and advances * | 212 845 | - 2 432 | 210 413 |
| Stage 1 (12-month ECL) | 184 302 | - 177 | 184 125 |
| Stage 2 (lifetime ECL) | 24 426 | - 395 | 24 031 |
| Stage 3 (lifetime ECL) | 3 680 | - 1 753 | 1 927 |
| Purchased or originated credit impaired assets (POCI) | 436 | - 107 | 330 |
| Debt Securities | 49 224 | - 11 | 49 212 |
| Stage 1 (12-month ECL) | 49 140 | - 8 | 49 132 |
| Stage 2 (lifetime ECL) | 78 | - 1 | 77 |
| Stage 3 (lifetime ECL) | 5 | - 2 | 4 |
| Purchased or originated credit impaired assets (POCI) | 0 | 0 | 0 |
| FINANCIAL ASSETS AT FAIR VALUE THROUGH OCI | |||
| Debt Securities | 17 711 | - 6 | 17 705 |
| Stage 1 (12-month ECL) | 17 711 | - 6 | 17 705 |
| Stage 2 (lifetime ECL) | 0 | 0 | 0 |
| Stage 3 (lifetime ECL) | 0 | 0 | 0 |
| Purchased or originated credit impaired assets (POCI) | 0 | 0 | 0 |
| 31-12-2023 | |||
| FINANCIAL ASSETS AT AMORTISED COST | |||
| Loans and advances * | 213 531 | - 2 474 | 211 057 |
| Stage 1 (12-month ECL) | 175 853 | - 146 | 175 708 |
| Stage 2 (lifetime ECL) | 33 571 | - 490 | 33 081 |
| Stage 3 (lifetime ECL) | 3 694 | - 1 750 | 1 944 |
| Purchased or originated credit impaired assets (POCI) | 412 | - 88 | 324 |
| Debt Securities | 51 384 | - 12 | 51 372 |
| Stage 1 (12-month ECL) | 51 300 | - 6 | 51 294 |
| Stage 2 (lifetime ECL) | 80 | - 4 | 76 |
| Stage 3 (lifetime ECL) | 5 | - 2 | 3 |
| Purchased or originated credit impaired assets (POCI) | 0 | 0 | 0 |
| FINANCIAL ASSETS AT FAIR VALUE THROUGH OCI | |||
| Debt Securities | 16 897 | - 5 | 16 892 |
| Stage 1 (12-month ECL) | 16 864 | - 4 | 16 861 |
| Stage 2 (lifetime ECL) | 33 | - 1 | 32 |
| Stage 3 (lifetime ECL) | 0 | 0 | 0 |
| Purchased or originated credit impaired assets (POCI) | 0 | 0 | 0 |
(*) The carrying value after impairment in this note is equal to the sum of the lines Loans and advances to credit institutions and investment firms (excl. reverse repos), Loans and advances to customers (excl. reverse repos) and Reverse repos in note 4.1 (in the column Measured at amortised cost)
A collective shift of an exposure of 12.4 billion euros from stage 1 to stage 2 has been applied at 31 March 2024, compared to 12.0 billion euros at 31 December 2023. It concerns stage 1 portfolios that are either:
In 1Q 2024 a combined net stage shift from stage 2 to stage 1 has taken place of approximately 8.5 billion euros in gross carrying amount with a net ECL release of 17 million euros. For the majority this is caused by the implementation of the new multi-tier approach for staging (see note 1.2) and for the remainder by a shift for KBC Commercial Finance exposure where the relative change in credit risk has been revisited based on the very low historical credit losses in this portfolio and taking into account the very short maturities. Both movements were introduced to better reflect the underlying credit risk since origination.
For more details on how KBC defines and determines (i) fair value and the fair value hierarchy and (ii) level 3 valuations reference is made to notes 4.4 up to and including 4.7 of the annual accounts 2023.
| (in millions of EUR) | 31-03-2024 | 31-12-2023 | ||||||
|---|---|---|---|---|---|---|---|---|
| Fair value hierarchy | Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total |
| FINANCIAL ASSETS AT FAIR VALUE | ||||||||
| Mandatorily measured at fair value through profit or loss (other than held for trading) |
15 132 | 99 | 900 | 16 130 | 14 253 | 107 | 851 | 15 212 |
| Held for trading | 3 382 | 5 645 | 786 | 9 813 | 2 991 | 4 625 | 711 | 8 327 |
| Designated at fair value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| At fair value through OCI | 16 385 | 2 352 | 677 | 19 415 | 15 290 | 2 628 | 669 | 18 587 |
| Hedging derivatives | 0 | 321 | 0 | 321 | 0 | 295 | 0 | 295 |
| Total | 34 899 | 8 418 | 2 363 | 45 680 | 32 534 | 7 656 | 2 231 | 42 422 |
| FINANCIAL LIABILITIES AT FAIR VALUE | ||||||||
| Held for trading | 1 039 | 3 926 | 1 180 | 6 145 | 1 429 | 4 582 | 1 039 | 7 050 |
| Designated at fair value | 14 290 | 275 | 1 148 | 15 713 | 13 432 | 202 | 1 157 | 14 791 |
| Hedging derivatives | 0 | 258 | 73 | 331 | 0 | 306 | 95 | 401 |
| Total | 15 329 | 4 459 | 2 401 | 22 189 | 14 862 | 5 090 | 2 290 | 22 242 |
During 1Q 2024, KBC transferred about 140 million euros' worth of financial assets and liabilities out of level 1 and into level 2. It also reclassified approximately 368 million euros' worth of financial assets and liabilities from level 2 to level 1. Most of these reclassifications were carried out due to a change in the liquidity of government and corporate bonds.
In 1Q 2024 significant movements in financial assets and liabilities classified in level 3 of the fair value hierarchy included the following:
The Contractual Service Margin (CSM) as included in the insurance contract liabilities, evolved from 2 244 million euros at the end of 2023 to 2 178 million euros at 31 March 2024, or a decrease of 65 million euros. This decrease is mainly explained by the negative change in best estimates reflected in the CSM (-67 million euros; mainly driven by parameter updates, changes in noneconomic & experience variances), CSM of new business (+44 million euros) was slightly higher compared to the CSM release in the income statement (-39 million euros).
| Quantities | 31-03-2024 | 31-12-2023 |
|---|---|---|
| Ordinary shares | 417 305 876 | 417 305 876 |
| of which ordinary shares that entitle the holder to a dividend payment | 403 462 498 | 408 508 807 |
| of which treasury shares | 13 846 573 | 8 801 316 |
| Additional information | ||
| Par value per share (in EUR) | 3.51 | 3.51 |
| Number of shares issued but not fully paid up | 0 | 0 |
The ordinary shares of KBC Group NV have no nominal value and are quoted on Euronext Brussels.
The treasury shares largely relate to shares bought in the share buyback programme and to a lesser extent to positions in shares of KBC Group to hedge outstanding derivatives on indices that include KBC Group shares.
In September 2023, KBC issued AT1 securities for 750 million euros (perpetual with a first callable after 5 years; temporary writedown trigger should the common equity ratio fall below 5.125%; initial coupon of 8.00% per year payable every six months). On 5 March 2024, KBC Group NV called the Additional Tier-1 Securities it issued in 2019. The European Central Bank (ECB) granted KBC permission to call this instrument, which had a nominal value of 500 million euros, and at the same time to call the subordinated inter-company loan of the same amount that KBC Group NV granted to KBC Bank NV.
KBC has in the years 2016-2022 provided irrevocable payment commitments (IPC's) for an amount of 90 million euros to the Single Resolution Fund (SRF) which are covered fully by cash collateral. In line with industry practice, following accounting treatment is applied to IPC's:
The recognition of the cash collateral as a financial asset is based on the consideration that, in any scenario, the collateral should be returned to the bank and that interest is received on the amount outstanding. In 4Q 2023, the General Court of the EU ruled that in a scenario in which a bank loses its banking license, it has no claim on the cash collateral. KBC decided to await the outcome of the appeal in this case at the European Court of Justice before considering the potential implications on the accounting treatment of IPC's.
The 90 million euros is deducted in the calculation of the common equity capital (CET1).
On 3 February 2023, KBC Bank Ireland closed the sale of substantially all of its assets and liabilities to Bank of Ireland Group. The transaction had an impact on KBC Group's P&L (1Q 2023) of +0.4 billion euros (for more information on the impact on the P&L of 2022 and 2023, see note 6.6 in the Annual report of 2023).
Significant non-adjusting events between the balance sheet date (31 March 2024) and the publication of this report (16 May 2024):


1Q 2024
Section not reviewed by the Auditor
The main source of credit risk is the loan portfolio of the bank. It includes all the loans and guarantees that KBC has granted to individuals, companies, governments and banks. Debt securities in the investment portfolio are included if they are issued by companies or banks. Government bonds are not included. The loan portfolio as defined in this section differs from 'Loans and advances to customers' in Note 4.1 of the 'Consolidated financial statements' section of the annual accounts 2023. For more information, please refer to 'Details of ratios and terms on KBC Group level'.
A snapshot of the banking portfolio is shown in the table below. Further on in this chapter, extensive information is provided on the credit portfolio of each business unit.
| Credit risk: loan portfolio overview | 31-03-2024 | 31-12-2023 |
|---|---|---|
| Total loan portfolio (in billions of EUR)1 | ||
| Amount outstanding and undrawn | 257 | 258 |
| Amount outstanding | 202 | 203 |
| Loan portfolio breakdown by business unit (as a % of the outstanding portfolio) | ||
| Belgium | 64.8% | 64.7% |
| Czech Republic | 19.2% | 19.3% |
| International Markets | 15.5% | 15.4% |
| Group Centre2 | 0.6% | 0.6% |
| Loan portfolio breakdown by counterparty sector (as a % of the outstanding portfolio) | ||
| Private individuals | 40.8% | 40.8% |
| Finance and insurance | 5.8% | 6.0% |
| Governments | 2.8% | 2.7% |
| Corporates | 50.6% | 50.5% |
| Services | 10.6% | 10.5% |
| Distribution | 8.3% | 8.3% |
| Real estate | 6.9% | 6.9% |
| Building & construction | 4.6% | 4.5% |
| Agriculture, farming, fishing | 2.9% | 2.9% |
| Automotive | 2.6% | 2.6% |
| Electricity | 1.7% | 1.8% |
| Food Producers | 1.7% | 1.8% |
| Metals | 1.6% | 1.6% |
| Chemicals | 1.5% | 1.5% |
| Machinery & Heavy equipment | 0.9% | 1.0% |
| Oil, gas & other fuels | 0.9% | 0.9% |
| Hotels, bars & restaurants | 0.8% | 0.8% |
| Shipping | 0.7% | 0.8% |
| Electrotechnics | 0.6% | 0.6% |
| Timber & wooden furniture | 0.5% | 0.5% |
| Other3 | 3.7% | 3.7% |
| Loan portfolio breakdown by region (as a % of the outstanding portfolio) | ||
| Belgium | 55.1% | 54.8% |
| Czech Republic | 18.3% | 18.4% |
| Slovakia | 6.3% | 6.3% |
| Hungary | 4.1% | 4.1% |
| Bulgaria | 5.2% | 5.1% |
| Rest of Western Europe | 7.6% | 7.6% |
| Rest of Central and Eastern Europe | 0.2% | 0.2% |
| of which: Russia and Ukraine | 0.01% | 0.01% |
| North America | 1.2% | 1.4% |
| Asia | 0.9% | 0.9% |
| Other | 1.1% | 1.1% |
| Loan portfolio breakdown by counterparty (as % of the outstanding portfolio) | ||
| Retail | 40.8% | 40.8% |
| of which: mortgages | 37.1% | 37.1% |
| of which: consumer finance | 3.7% | 3.7% |
| SME | 22.1% | 21.8% |
| Corporate | 37.1% | 37.4% |
| 31-03-2024 | 31-12-2023 | |
|---|---|---|
| Loan portfolio breakdown by IFRS 9 ECL stage (as % of the outstanding portfolio) | ||
| Stage 1 (credit risk has not increased significantly since initial recognition) | 85.4% | 80.1% |
| of which: PD 1 - 4 | 66.8% | 64.5% |
| of which: PD 5 - 9 including unrated | 18.6% | 15.5% |
| Stage 2 (credit risk has increased significantly since initial recognition – not credit impaired) incl. POCI4 | 12.5% | 17.9% |
| of which: PD 1 - 4 | 2.4% | 5.1% |
| of which: PD 5 - 9 including unrated | 10.1% | 12.7% |
| Stage 3 (credit risk has increased significantly since initial recognition – credit impaired) incl. POCI4 | 2.1% | 2.1% |
| of which: PD 10 impaired loans | 1.1% | 1.1% |
| of which: more than 90 days past due (PD 11+12) | 1.0% | 1.0% |
| Impaired loan portfolio (in millions of EUR) | ||
| Impaired loans (PD10 + 11 + 12) | 4 299 | 4 221 |
| of which: more than 90 days past due | 2 067 | 2 051 |
| Impaired loans ratio (%) | ||
| Belgium | 2.1% | 2.0% |
| Czech Republic | 1.4% | 1.4% |
| International Markets | 1.7% | 1.8% |
| Group Centre2 | 37.0% | 36.2% |
| Total | 2.1% | 2.1% |
| of which: more than 90 days past due | 1.0% | 1.0% |
| Loan loss impairment (in millions of EUR) | ||
| Loan loss Impairment for Stage 1 portfolio | 200 | 168 |
| Loan loss Impairment for Stage 2 portfolio | 408 | 502 |
| Loan loss Impairment for Stage 3 portfolio | 1 915 | 1 888 |
| of which: more than 90 days past due | 1 429 | 1 459 |
| Cover ratio of impaired loans (%) | ||
| Loan loss impairments for stage 3 portfolio / impaired loans | 44.5% | 44.7% |
| of which: more than 90 days past due | 69.2% | 71.2% |
| Cover ratio of impaired loans, mortgage loans excluded (%) | ||
| Loan loss impairments for stage 3 portfolio / impaired loans, mortgage loans excluded | 46.9% | 47.4% |
| of which: more than 90 days past due | 71.9% | 74.2% |
| Credit cost ratio (%) | ||
| Belgium | 0.11% | 0.06% |
| Czech Republic | 0.04% | -0.18% |
| International Markets | -0.25% | -0.06% |
| Slovakia | -0.36% | -0.07% |
| Hungary | -0.50% | -0.14% |
| Bulgaria | 0.07% | 0.00% |
| Group Centre | 0.20% | 0.07% |
| Total | 0.04% | 0.00% |
1 Outstanding portfolio includes all on-balance sheet commitments and off-balance sheet guarantees but excludes off-balance sheet undrawn commitments; the amounts are measured
in Gross Carrying Amounts 2 Business Unit Group Centre = part of non-legacy portfolio assigned to BU Group, activities in wind-down (e.g. ex-Antwerp Diamond Bank), The presence of the residual portfolios of the activities in wind-down explains the high share of impaired loans 3 Other includes corporate sectors not exceeding 0.5% concentration and unidentified sectors
4 Purchased or originated credit impaired assets
As of 2022, a collective shift to stage 2 has been applied for the stage 1 portfolios that are indirectly exposed to military conflicts and vulnerable to the geopolitical and macroeconomic uncertainties (for more information see note 4.2.1). In 1Q 2024, the remaining direct exposure to Russia, Ukraine and Belarus is 17 million euros or 0.01% of the outstanding loan portfolio (100% stage 3).
The decrease of the stage 2 ratio is mainly caused by a revised staging methodology (change from indicator based on 12 months probability of default to lifetime, for more information see note 1.2) and for the remainder by a shift for KBC Commercial Finance exposure where the relative change in credit risk has been revisited based on the very low historical credit losses in this portfolio and the very short maturities. Both movements were introduced to better reflect the underlying credit risk since origination.
Impaired loans are loans for which full (re)payment of the contractual cash flows is deemed unlikely. This coincides with KBC's Probability-of-Default-classes 10, 11 and 12 (see annual accounts FY 2022 - section on credit risk for more information on PD classification). These impaired loans are equal to 'non-performing loans' under the definition used by EBA.
| Loan portfolio per Business Unit | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 31-03-2024, in millions of EUR | Business Unit Belgium1 | Business Unit Czech Republic | Business Unit International Markets | Business Unit Group Centre2 | ||||||||
| Total portfolio outstanding | 131 095 | 38 729 | 31 255 | 1 147 | ||||||||
| Counterparty break down | % outst. | % outst. | % outst. | % outst. | ||||||||
| retail | 46 252 | 35% | 22 284 | 58% | 14 057 | 45% | 0 | 0% | ||||
| o/w mortgages | 44 569 | 34% | 19 725 | 51% | 10 796 | 35% | 0 | 0% | ||||
| o/w consumer finance | 1 683 | 1% | 2 559 | 7% | 3 261 | 10% | 0 | 0% | ||||
| SME | 35 339 | 27% | 5 664 | 15% | 3 617 | 12% | 0 | 0% | ||||
| corporate | 49 505 | 38% | 10 780 | 28% | 13 582 | 43% | 1 147 | 100% | ||||
| Mortgage loans | % outst. | ind. LTV | % outst. | ind. LTV | % outst. | ind. LTV | % outst. | ind. LTV | ||||
| total | 44 569 | 34% | 53% | 19 725 | 51% | 49% | 10 795 | 35% | 58% | 0 | 0% | 0% |
| o/w FX mortgages | 0 | 0% | - | 0 | 0% | - | 85 | 0% | 45% | 0 | 0% | - |
| o/w ind. LTV > 100% | 370 | 0% | - | 17 | 0% | - | 80 | 0% | - | 0 | 0% | - |
| Probability of default (PD) | % outst. | % outst. | % outst. | % outst. | ||||||||
| low risk (PD 1-4; 0.00%-0.80%) | 99 449 | 76% | 22 596 | 58% | 17 197 | 55% | 680 | 59% | ||||
| medium risk (PD 5-7; 0.80%-6.40%) | 25 889 | 20% | 14 110 | 36% | 12 219 | 39% | 42 | 4% | ||||
| high risk (PD 8-9; 6.40%-100.00%) | 2 715 | 2% | 1 471 | 4% | 1 189 | 4% | 0 | 0% | ||||
| impaired loans (PD 10 - 12) | 2 787 | 2% | 549 | 1% | 538 | 2% | 425 | 37% | ||||
| unrated | 255 | 0% | 2 | 0% | 113 | 0% | 0 | 0% | ||||
| Overall risk indicators | stage 3 imp. | % cover | stage 3 imp. | % cover | stage 3 imp. | % cover | stage 3 imp. | % cover | ||||
| outstanding impaired loans | 2 787 | 1 055 | 38% | 549 | 247 | 45% | 538 | 245 | 45% | 425 | 368 | 87% |
| o/w PD 10 impaired loans | 1 653 | 323 | 20% | 241 | 66 | 28% | 273 | 74 | 27% | 66 | 22 | 34% |
| o/w more than 90 days past due (PD 11+12 | 1 134 | 732 | 65% | 309 | 181 | 59% | 265 | 170 | 64% | 359 | 346 | 96% |
| all impairments (stage 1+2+3) | 1 322 | 426 | 406 | 369 | ||||||||
| o/w stage 1+2 impairments (incl. POCI) | 267 | 179 | 161 | 1 | ||||||||
| o/w stage 3 impairments (incl. POCI) | 1 055 | 247 | 245 | 368 | ||||||||
| 2023 Credit cost ratio (CCR)3 | 0.06% | -0.18% | -0.06% | 0.07% | ||||||||
| 2024 Credit cost ratio (CCR)3 - YTD |
0.11% | 0.04% | -0.25% | 0.20% |
1 Business Unit Belgium = KBC Bank (all retail and corporate credit lending activities including the foreign branches, part of non-legacy portfolio assigned to BU Belgium), CBC, KBC Lease Belgium, KBC Immolease, KBC Commercial Finance
2 Business Unit Group Centre = part of non-legacy portfolio assigned to BU Group and activities in wind-down (e.g. ex-Antwerp Diamond Bank)
3 CCR at country level in local currency
| 31-03-2024, in millions of EUR | Slovakia | Hungary | Bulgaria | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Total portfolio outstanding | 12 282 | 8 299 | 10 674 | |||||||
| Counterparty break down | % outst. | % outst. | % outst. | |||||||
| retail | 7 066 | 58% | 2 767 | 33% | 4 224 | 40% | ||||
| o/w mortgages | 6 551 | 53% | 1 829 | 22% | 2 415 | 23% | ||||
| o/w consumer finance | 515 | 4% | 938 | 11% | 1 809 | 17% | ||||
| SME | 1 223 | 10% | 89 | 1% | 2 305 | 22% | ||||
| corporate | 3 993 | 33% | 5 443 | 66% | 4 146 | 39% | ||||
| Mortgage loans | % outst. | ind. LTV | % outst. | ind. LTV | % outst. | ind. LTV | ||||
| total | 6 551 | 53% | 62% | 1 829 | 22% | 46% | 2 415 | 23% | 60% | |
| o/w FX mortgages | 0 | 0% | - | 1 | 0% | 49% | 85 | 1% | 45% | |
| o/w ind. LTV > 100% | 38 | 0% | - | 23 | 0% | 18 | 0% | - | ||
| Probability of default (PD) | % outst. | % outst. | % outst. | |||||||
| low risk (PD 1-4; 0.00%-0.80%) | 8 164 | 66% | 4 640 | 56% | 4 394 | 41% | ||||
| medium risk (PD 5-7; 0.80%-6.40%) | 3 364 | 27% | 3 348 | 40% | 5 507 | 52% | ||||
| high risk (PD 8-9; 6.40%-100.00%) | 559 | 5% | 191 | 2% | 439 | 4% | ||||
| impaired loans (PD 10 - 12) | 175 | 1% | 119 | 1% | 243 | 2% | ||||
| unrated | 20 | 0% | 2 | 0% | 91 | 1% | ||||
| Overall risk indicators | stage 3 imp. | % cover | stage 3 imp. | % cover | stage 3 imp. | % cover | ||||
| outstanding impaired loans | 175 | 90 | 51% | 119 | 38 | 32% | 243 | 117 | 48% | |
| o/w PD 10 impaired loans | 71 | 19 | 26% | 91 | 21 | 23% | 111 | 34 | 31% | |
| o/w more than 90 days past due (PD 11+12) | 105 | 71 | 68% | 28 | 17 | 60% | 133 | 83 | 62% | |
| all impairments (stage 1+2+3) | 143 | 89 | 175 | |||||||
| o/w stage 1+2 impairments (incl. POCI) | 53 | 51 | 58 | |||||||
| o/w stage 3 impairments (incl. POCI) | 90 | 38 | 117 | |||||||
| 2023 Credit cost ratio (CCR)1 | -0.07% | -0.14% | 0.00% | |||||||
| 2024 Credit cost ratio (CCR)1 - YTD |
-0.36% | -0.50% | 0.07% |
1 CCR at country level in local currency
KBC reports its solvency at group, banking and insurance level, calculating it on the basis of IFRS figures and the relevant guidelines issued by the competent regulator.
We report the solvency of the group, the bank and the insurance company based on IFRS data and according to the rules imposed by the regulator. For the KBC group, this implies that we calculate our solvency ratios based on CRR/CRD. This regulation entered gradually into force as of 1 January 2014.
KBC makes use of the IFRS 9 transitional measures (applied from the second quarter of 2020). These transitional measures make it possible to add back a portion of the increased impairment charges to common equity capital (CET1), during a transitional period until 31 December 2024.
Based on CRR/CRD, profit can be included in CET1 capital only after the profit appropriation decision by the final decision body, for KBC Group it is the General Meeting. ECB can allow to include interim or annual profit in CET1 capital before the decision by the General Meeting. In that case, the foreseeable dividend should be deducted from the profit that is included in CET1. Considering that our Dividend Policy of "at least 50%" does not include a maximum, KBC Group no longer requests ECB approval to include interim or annual profit in CET1 capital before the decision by the General Meeting. As such, the annual profit of 2023 and the final dividend re. 2023 is recognised in the official (transitional) CET1 of the 1st quarter 2024, which is reported after the General Meeting. The (informal) fully loaded 31-12-2023 figures already fully reflected the 2023 profit and proposed dividend.
As regard 2024, the interim profit is included in the fully loaded CET1 (taking into account 50% pay-out in line with our Dividend Policy plus the approximately 280 million euros extraordinary interim dividend that relates to the distribution of the surplus capital at year-end 2023, for more information see note 6.8), while no interim profit is recognised in the official (transitional) CET1.
The general rule under CRR/CRD for insurance participations is that an insurance participation is deducted from common equity at group level, unless the competent authority grants permission to apply a risk weighting instead (Danish compromise). As of the fourth quarter of 2020, the revised CRR/CRD requires the use of the equity method, unless the competent authority allows institutions to apply a different method. KBC Group has received ECB approval to continue to use the historical carrying value for risk weighting (370%), after having deconsolidated KBC Insurance from the group figures.
In addition to the solvency ratios under CRR/CRD, KBC is considered a financial conglomerate since it covers both significant banking and insurance activities. Therefore KBC also has to disclose its solvency position as calculated in accordance with the Financial Conglomerate Directive (FICOD; 2002/87/EC). This implies that available capital is calculated on the basis of the consolidated position of the group and the eligible items recognised as such under the prevailing sectorial rules, which are CRR/CRD for the banking business and Solvency II for the insurance business. The capital requirement for the insurance business based on Solvency II is multiplied by 12.5 to obtain a risk weighted asset equivalent.
The Internal Rating Based (IRB) approach is since its implementation in 2008 the primary approach to calculate KBC's risk weighted assets. This is, based on a full application of all the CRR/CDR rules, used for approximately 73% of the weighted credit risks. The remaining weighted credit risks (ca. 27%) are calculated according to the Standardised approach.
The overall capital requirement (CET1) that KBC is to uphold is set at 10.89% (fully loaded, Danish Compromise which includes the CRR/CRD minimum requirement (4.50%), the Pillar 2 Requirement (1.05% P2R, taking into account CRD V Art 104a(4)) and the buffers set by national competent authorities (2.50% Capital Conservation Buffer, 1.50% buffer for other systemically important banks, 0.14% Systemic Risk Buffer and 1.20% Countercyclical Buffer). Furthermore ECB has set a Pillar 2 Guidance of 1.25%. In line with CRD V Art. 104a(4), ECB allows banks to satisfy the P2R (1.86%) with additional tier-1 instruments (up to 1.5/8) and tier-2 instruments (up to 2/8) based on the same relative weights as allowed for meeting the 8% Pillar 1 Requirement.
Distributions (being dividend payments, payments related to additional tier 1 instruments or variable remuneration) are limited in case the combined buffer requirements described above are breached. This limitation is also referred to as "Maximum Distributable Amount" or "MDA" thresholds.
The next table provides an overview of the buffers KBC Group has compared to these thresholds, both on an actuals basis (i.e. versus the regulatory targets that apply at the reporting date) and a fully loaded basis (i.e. versus the regulatory targets that will apply going forward).
| Buffer vs. Overall Capital Requirement (in millions of EUR) |
31-03-2024 | 31-12-2023 | |||
|---|---|---|---|---|---|
| (consolidated, under CRR, Danish compromise method) | Fully loaded | Actuals | Fully loaded | Actuals | |
| CET1 Pillar 1 minimum | 4.50% | 4.50% | 4.50% | 4.50% | |
| Pillar 2 requirement to be satisfied with CET1 | 1.05% | 1.05% | 1.05% | 1.05% | |
| Capital conservation buffer | 2.50% | 2.50% | 2.50% | 2.50% | |
| Buffer for systemically important institutions (O-SII) | 1.50% | 1.50% | 1.50% | 1.50% | |
| Systemic Risk Buffer (SRyB) | 0.14% | 0.21% | 0.14% | 0.21% | |
| Entity-specific countercyclical buffer | 1.20% | 0.71% | 1.24% | 0.67% | |
| Overall Capital Requirement (OCR) - with P2R split, CRD Art. 104a(4) | 10.89% | 10.46% | 10.92% | 10.43% | |
| CET1 used to satisfy shortfall in AT1 bucket | 0.32% | 0.32% | 0.30% | 0.30% | |
| CET1 used to satisfy shortfall in T2 bucket | 0.00% | 0.00% | 0.45% | 0.36% | |
| CET1 requirement for MDA | 11.20% | 10.78% | 11.68% | 11.09% | |
| CET1 capital | 17 033 | 17 215 | 17 236 | 15 639 | |
| CET1 buffer (= buffer compared to MDA) | 4 251 | 4 921 | 4 036 | 3 105 |
Note: CET1 capital used to satisfy the shortfall in the AT1 and T2 buckets for both the pillar 1 minimum and the pillar 2 requirement. The fully loaded T2 capital excludes the T2 instruments grandfathered under CRR2; these T2 instruments are included in the actual (transitional) T2 capital for the period of grandfathering, in line with CRR2 and the COREP 3.0 reporting framework.
Following table groups the solvency on the level of KBC Group according to different methodologies and calculation methods, including the deduction method.
| Overview of KBC Group's capital ratios | denominator | |||
|---|---|---|---|---|
| (in millions of EUR) | numerator | (total | ||
| 31-03-2024 | (common equity) |
weighted risk volume) |
ratio (%) | |
| Common Equity ratio | ||||
| Danish Compromise | Fully loaded | 17 033 | 114 101 | 14.93% |
| Deduction Method | Fully loaded | 16 297 | 109 299 | 14.91% |
| Financial Conglomerates Directive | Fully loaded | 18 542 | 130 651 | 14.19% |
| Danish Compromise | Transitional | 17 215 | 114 101 | 15.09% |
| Deduction Method | Transitional | 16 497 | 109 342 | 15.09% |
| Financial Conglomerates Directive | Transitional | 18 725 | 130 651 | 14.33% |
KBC's fully loaded CET1 ratio of 14.93% at the end of March 2024 represents a solid capital buffer of 3.73% compared with the Maximum Distributable Amount (MDA) of 11.20%.
After having received ECB approval, the Board of Directors decided to distribute 1.3 billion euros in the form of a share buyback, which has started on 11 August 2023 and will end by 31 July 2024. As such, 1.3 billion euros is deducted from the fully loaded and transitional Common equity ratio as of 3Q 2023. As at 31 March 2024, an amount of 814 million euros have been purchased (deducted in IFRS parent shareholders capital); the remaining 486 million euro to be purchased is deducted separately in the fully loaded and transitional Common equity ratio.
The Annual General Meeting of shareholders (on 2 May 2024) approved a final gross dividend of 4.15 euros per share related to the accounting year 2023, of which:
On 15 May 2024, the Board of Directors decided to distribute the surplus capital above the fully loaded CET1 ratio of 15% at 31 December 2023 (approximately 280 million euros) in the format of an extraordinary interim dividend (of 0.70 euros per share). For more information see note 6.8.
| 31-03-2024 | 31-03-2024 | 31-12-2023 | 31-12-2023 | |
|---|---|---|---|---|
| In millions of EUR | Fully loaded | Transitional | Fully loaded | Transitional |
| Total regulatory capital (after profit appropriation) | 22 617 | 22 903 | 21 260 | 19 768 |
| Tier-1 capital | 18 783 | 18 965 | 18 986 | 17 389 |
| Common equity | 17 033 | 17 215 | 17 236 | 15 639 |
| Parent shareholders' equity (after deconsolidating KBC Insurance) | 21 113 | 21 023 | 21 181 | 18 209 |
| Intangible fixed assets, incl deferred tax impact (-) | - 662 | - 662 | - 712 | - 712 |
| Goodwill on consolidation, incl deferred tax impact (-) | - 1 057 | - 1 057 | - 1 070 | - 1 070 |
| Minority interests | 0 | 0 | 0 | 0 |
| Hedging reserve (cash flow hedges) (-) | 575 | 575 | 579 | 579 |
| Valuation diff. in financial liabilities at fair value - own credit risk (-) | - 29 | - 29 | - 29 | - 29 |
| Value adjustment due to the requirements for prudent valuation (-) | - 32 | - 32 | - 24 | - 24 |
| Dividend payout (-) | - 1 784 | - 1 553 | - 1 287 | 0 |
| Share buyback (part not yet executed) (-) | - 486 | - 486 | - 803 | - 803 |
| Coupon of AT1 instruments (-) | - 17 | - 17 | - 26 | - 26 |
| Deduction re. financing provided to shareholders (-) | - 20 | - 20 | - 56 | - 56 |
| Deduction re. Irrevocable payment commitments (-) | - 90 | - 90 | - 90 | - 90 |
| Deduction re NPL backstops (-) | - 202 | - 202 | - 204 | - 204 |
| Deduction re pension plan assets (-) | - 157 | - 157 | - 121 | - 121 |
| IRB provision shortfall (-) | - 32 | 0 | - 4 | 0 |
| Deferred tax assets on losses carried forward (-) | - 87 | - 87 | - 98 | - 98 |
| Transitional adjustments to CET1 | 0 | 9 | 0 | 84 |
| Limit on deferred tax assets from timing differences relying on future profitability and significant participations in financial sector entities (-) |
0 | 0 | 0 | 0 |
| Additional going concern capital | 1 750 | 1 750 | 1 750 | 1 750 |
| CRR compliant AT1 instruments | 1 750 | 1 750 | 1 750 | 1 750 |
| Minority interests to be included in additional going concern capital | 0 | 0 | 0 | 0 |
| Tier 2 capital | 3 834 | 3 938 | 2 273 | 2 379 |
| IRB provision excess (+) | 256 | 187 | 277 | 265 |
| Transitional adjustments to T2 | 0 | - 4 | 0 | - 60 |
| Subordinated liabilities | 3 578 | 3 755 | 1 997 | 2 174 |
| Subordinated loans non-consolidated financial sector entities (-) | 0 | 0 | 0 | 0 |
| Minority interests to be included in tier 2 capital | 0 | 0 | 0 | 0 |
| Total weighted risk volume | 114 101 | 114 101 | 113 038 | 113 029 |
| Banking | 104 285 | 104 285 | 103 201 | 103 192 |
| Insurance | 9 133 | 9 133 | 9 133 | 9 133 |
| Holding activities | 746 | 746 | 710 | 710 |
| Elimination of intercompany transactions | - 63 | - 63 | - 6 | - 6 |
| Solvency ratios | ||||
| Common equity ratio | 14.93% | 15.09% | 15.25% | 13.84% |
| Tier-1 ratio | 16.46% | 16.62% | 16.80% | 15.38% |
| Total capital ratio | 19.82% | 20.07% | 18.81% | 17.49% |
Note:
• For the composition of the banking RWA, see section 'Solvency banking and insurance activities separately' further in this memo.
• As at 31-03-2024, the difference between the fully loaded total own funds (22 617 million euros, interim profit after 50% pay-out re. 2024 is included) and the transitional own funds (22 903 million euros, interim profit after 50% pay-out re. 2024 is not included) is explained by the net interim result for 2024 (372 million euros under the Danish Compromise method), the 50% pay-out (-231 million euros dividend accrual), the interim dividend (-282 million euros based on number of shares 31-03-2024), the impact of the IFRS 9 transitional measures and IRB excess/shortfall (31 million euros) and the grandfathered tier-2 subordinated debt instruments (-177 million euros).
• At year-end 2023, the difference between the fully loaded total own funds (21 260 million euros; profit and dividend re. 2023 is included) and the transitional own funds (19 768 million euros; profit and dividend re. 2023 is not included) as at 31-12-2023 is explained by the net result for 2023 (3 383 million euros under the Danish Compromise method), the proposed final dividend (-1 698 million euros dividend accrual), the impact of the IFRS 9 transitional measures and IRB excess/shortfall (-15 million euros) and the grandfathered tier-2 subordinated debt instruments (-177 million euros).
| Leverage ratio KBC Group | 31-03-2024 | 31-03-2024 | 31-12-2023 | 31-12-2023 |
|---|---|---|---|---|
| In millions of EUR | Fully loaded | Transitional | Fully loaded | Transitional |
| Tier-1 capital | 18 783 | 18 965 | 18 986 | 17 389 |
| Total exposures | 346 545 | 346 562 | 333 791 | 333 894 |
| Total Assets | 359 477 | 359 477 | 346 921 | 346 921 |
| Deconsolidation KBC Insurance | -32 035 | -32 035 | -30 980 | -30 980 |
| Transitional adjustment | 0 | 17 | 0 | 103 |
| Adjustment for derivatives | -1 159 | -1 159 | -1 341 | -1 341 |
| Adjustment for regulatory corrections in determining Basel III Tier-1 capital | -2 216 | -2 216 | -2 286 | -2 286 |
| Adjustment for securities financing transaction exposures | 1 508 | 1 508 | 1 357 | 1 357 |
| Central Bank exposure | 0 | 0 | 0 | 0 |
| Off-balance sheet exposures | 20 970 | 20 970 | 20 119 | 20 119 |
| Leverage ratio | 5.42% | 5.47% | 5.69% | 5.21% |
At the end of March 2024, the fully loaded leverage ratio decreased compared to December 2023, due to lower Tier-1 capital (driven mainly by 282 million euros extraordinary interim dividend) and higher leverage ratio exposure chiefly as a result of higher cash and cash balances with central banks (for more information see balance sheet in the Consolidated financial statements section).
. . .
As is the case for the KBC group, the solvency of KBC Bank is calculated based on CRR/CRD. The solvency of KBC Insurance is calculated on the basis of Solvency II rules as they became effective on 1 January 2016.
The tables below show the tier-1 and CAD ratios calculated under Basel III (CRR/CRD) for KBC Bank, as well as the solvency ratio of KBC Insurance under Solvency II.
| Regulatory capital requirements KBC Bank (consolidated) | 31-03-2024 | 31-03-2024 | 31-12-2023 | 31-12-2023 |
|---|---|---|---|---|
| (in millions of EUR) | Fully loaded | Transitional | Fully loaded | Transitional |
| Total regulatory capital, after profit appropriation | 20 411 | 20 303 | 19 375 | 17 952 |
| Tier-1 capital | 16 898 | 16 863 | 16 924 | 15 573 |
| Common equity | 15 148 | 15 113 | 15 174 | 13 823 |
| Parent shareholders' equity | 17 916 | 17 839 | 17 695 | 15 450 |
| Solvency adjustments | -2 768 | -2 726 | -2 521 | -1 627 |
| Additional going concern capital | 1 750 | 1 750 | 1 750 | 1 750 |
| Tier-2 capital | 3 513 | 3 440 | 2 451 | 2 379 |
| Total weighted risk volume | 104 285 | 104 285 | 103 201 | 103 192 |
| Credit risk | 89 145 | 89 145 | 88 051 | 88 042 |
| Market risk | 2 106 | 2 106 | 2 116 | 2 116 |
| Operation risk | 13 034 | 13 034 | 13 034 | 13 034 |
| Common equity ratio | 14.5% | 14.5% | 14.7% | 13.4% |
| Own Funds | 4 157 | 4 130 |
|---|---|---|
| Tier 1 | 3 656 | 3 629 |
| IFRS Parent shareholders' equity | 3 526 | 3 302 |
| Dividend payout | - 326 | - 233 |
| Deduction intangible assets and goodwill (after tax) | - 199 | - 198 |
| Valuation differences (after tax) | 482 | 597 |
| Volatility adjustment | 124 | 137 |
| Other | 49 | 25 |
| Tier 2 | 501 | 501 |
| Subordinated liabilities | 501 | 501 |
| Solvency Capital Requirement (SCR) | 2 055 | 2 005 |
| Market risk | 1 487 | 1 434 |
| Non-life | 778 | 786 |
| Life | 1 173 | 1 131 |
| Health | 244 | 278 |
| Counterparty | 120 | 124 |
| Diversification | -1 290 | -1 293 |
| Other | - 457 | - 455 |
| Solvency II ratio | 202% | 206% |
Besides the ECB and NBB, which supervise KBC on a going concern basis, KBC is also subject to requirements set by the Single Resolution Board (SRB). The SRB is developing resolution plans for the major banks in the euro area. The resolution plan for KBC is based on a Single Point of Entry (SPE) approach at the level of KBC Group with 'bail-in' as the primary resolution tool. MREL measures the amount of own funds and eligible liabilities that can be credibly and feasibly bailed-in.
In April 2023, the SRB formally communicated to KBC binding MREL targets (under BRRD2) for 01-01-2024, expressed as a percentage of Risk Weighted Assets (RWA) and Leverage Ratio Exposure Amount (LRE):
Besides a total MREL amount, BRRD2 also requires KBC to maintain a certain part of MREL in subordinated format (i.e. instruments subordinated to liabilities, excluded from bail-in).
The binding subordinated MREL targets are:
At the end of March 2024, the MREL ratio stands at 33.2% as a % of RWA (versus 30.7% as at the end 2023) and at 10.9% as % of LRE (versus 10.4% as at the end of 2023). The increase of the MREL ratio in % of RWA is driven mainly by the increased common equity due to recognition of retained earnings in 1Q 2024 and increased Tier-2 capital, only partially offset by increase of total weighted risk volume. The increase of the MREL ratio in % of LRE is driven mainly by the growth in available MREL, which more than offset the increased leverage exposure.
(1) Combined Buffer Requirement (transitional) = Conservation Buffer (2.50%) + O-SII Buffer (1.50%) + Countercyclical Buffer (0.71%) + Systemic Risk Buffer (0.21%) comes on top of the MREL target as a percentage of RWA
Details on our segments or business units are available in the company presentation.
Note: The ECB approved to apply the IFRS9 transitional arrangements from 2Q 2020, as such the difference between fully loaded and the transitional measures are assigned to Group Centre. In other words, the RWA, allocated capital and the ROAC of the different countries remain based on fully loaded.
| KBC Group | |||||
|---|---|---|---|---|---|
| (in millions of EUR) | 1Q 2024 | 4Q 2023 | 3Q 2023 | 2Q 2023 | 1Q 2023 |
| Breakdown P&L | |||||
| Net interest income | 1 369 | 1 360 | 1 382 | 1 407 | 1 324 |
| Insurance revenues before reinsurance | 714 | 683 | 699 | 666 | 631 |
| Non-life | 598 | 584 | 587 | 567 | 543 |
| Life | 116 | 99 | 113 | 100 | 88 |
| Dividend income | 7 | 12 | 10 | 30 | 8 |
| Net result from financial instruments at fair value through profit or loss & Insurance finance income and expense (for contracts issued) |
- 55 | - 40 | - 8 | 33 | 24 |
| Net fee and commission income | 614 | 600 | 588 | 584 | 576 |
| Net other income | 58 | 60 | 44 | 54 | 498 |
| TOTAL INCOME | 2 708 | 2 674 | 2 715 | 2 775 | 3 060 |
| Operating expenses (excl. Opex allocated to insurance service expenses) | - 1 431 | - 1 085 | - 1 011 | - 1 019 | - 1 501 |
| Total Opex without bank and insurance tax | - 1 063 | - 1 169 | - 1 101 | - 1 090 | - 1 077 |
| Total bank and insurance tax | - 518 | - 36 | - 29 | - 51 | - 571 |
| Minus: Opex allocated to insurance service expenses | 150 | 120 | 119 | 123 | 147 |
| Insurance service expenses before reinsurance | - 563 | - 567 | - 540 | - 523 | - 490 |
| Of which Insurance commissions paid | - 89 | - 94 | - 87 | - 82 | - 77 |
| Non-life | - 489 | - 509 | - 485 | - 457 | - 418 |
| of which Non-life - Claim related expenses | - 293 | - 328 | - 308 | - 284 | - 237 |
| Life | - 73 | - 58 | - 55 | - 66 | - 72 |
| Net result from reinsurance contracts held | - 18 | - 16 | - 22 | - 22 | - 30 |
| Impairment | - 16 | - 170 | - 63 | - 8 | 26 |
| on FA at amortised cost and at FVOCI | - 16 | 5 | - 36 | 23 | 24 |
| on goodwill | 0 | - 109 | 0 | 0 | 0 |
| other | 0 | - 66 | - 27 | - 31 | 1 |
| Share in results of associated companies and joint ventures | 0 | 0 | 0 | - 1 | - 3 |
| RESULT BEFORE TAX | 680 | 836 | 1 079 | 1 202 | 1 062 |
| Income tax expense | - 175 | - 159 | - 203 | - 236 | - 180 |
| RESULT AFTER TAX | 506 | 677 | 877 | 966 | 882 |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | 506 | 677 | 877 | 966 | 882 |
| Banking | 356 | 566 | 722 | 790 | 755 |
| Insurance | 133 | 108 | 134 | 159 | 125 |
| Holding activities | 16 | 3 | 20 | 17 | 2 |
| Breakdown Loans and deposits | |||||
| Total customer loans excluding reverse repos (end of period) | 183 722 | 183 613 | 181 821 | 182 005 | 179 520 |
| of which Mortgage loans (end of period) | 75 311 | 75 482 | 75 105 | 75 255 | 74 811 |
| Customer deposits and debt certificates excl. repos (end of period) | 263 700 | 259 491 | 260 383 | 264 167 | 248 882 |
| Insurance related liabilities (including Inv. Contracts) | |||||
| Life insurance | 27 938 | 27 323 | 25 754 | 26 204 | 25 626 |
| Liabilities under investment contracts (IFRS 9) | 14 319 | 13 461 | 12 655 | 12 751 | 12 164 |
| Insurance contract liabilities (IFRS 17) | 13 618 | 13 862 | 13 099 | 13 453 | 13 463 |
| Non-life insurance | 2 984 | 2 922 | 2 821 | 2 842 | 2 819 |
| Performance Indicators | |||||
| Risk-weighted assets, banking (Basel III fully loaded, end of period) | 114 101 | 113 038 | 115 255 | 108 945 | 107 686 |
| Required capital, insurance (end of period) | 2 055 | 2 005 | 2 034 | 2 015 | 1 965 |
| Allocated capital (end of period) | 13 517 | 13 788 | 14 068 | 13 334 | 13 141 |
| Return on allocated capital (ROAC, YTD) | 15% | 25% | 27% | 28% | 27% |
| Cost/income ratio without banking and insurance tax (YTD) | 43% | 43% | 41% | 40% | 38% |
| Combined ratio, non-life insurance (YTD) | 85% | 87% | 85% | 84% | 83% |
| Net interest margin, banking (QTD) | 2.08% | 1.99% | 2.04% | 2.11% | 2.04% |
| Business unit Belgium | |||||
|---|---|---|---|---|---|
| (in millions of EUR) | 1Q 2024 | 4Q 2023 | 3Q 2023 | 2Q 2023 | 1Q 2023 |
| Breakdown P&L | |||||
| Net interest income | 809 | 809 | 812 | 857 | 769 |
| Insurance revenues before reinsurance | 443 | 416 | 430 | 407 | 385 |
| Non-life | 365 | 355 | 354 | 344 | 333 |
| Life | 78 | 61 | 76 | 63 | 52 |
| Dividend income | 7 | 11 | 7 | 27 | 7 |
| Net result from financial instruments at fair value through profit or loss & | |||||
| Insurance finance income and expense (for contracts issued) | - 101 | - 86 | - 47 | - 36 | - 29 |
| Net fee and commission income | 409 | 393 | 384 | 378 | 382 |
| Net other income | 54 | 57 | 43 | 48 | 87 |
| TOTAL INCOME | 1 621 | 1 600 | 1 628 | 1 681 | 1 603 |
| Operating expenses (excl. Opex allocated to insurance service expenses) | - 841 | - 583 | - 556 | - 545 | - 849 |
| Total Opex without bank and insurance tax | - 606 | - 643 | - 625 | - 611 | - 584 |
| Total bank and insurance tax | - 317 | - 8 | 0 | - 6 | - 347 |
| Minus: Opex allocated to insurance service expenses | 82 | 68 | 70 | 72 | 82 |
| Insurance service expenses before reinsurance | - 340 | - 341 | - 327 | - 313 | - 304 |
| Of which Insurance commissions paid | - 57 | - 57 | - 58 | - 53 | - 51 |
| Non-life | - 289 | - 305 | - 292 | - 269 | - 250 |
| of which Non-life - Claim related expenses | - 191 | - 211 | - 194 | - 173 | - 156 |
| Life | - 52 | - 36 | - 35 | - 44 | - 54 |
| Net result from reinsurance contracts held | - 24 | - 19 | - 7 | - 16 | - 21 |
| Impairment | - 37 | - 28 | - 58 | - 40 | 11 |
| on FA at amortised cost and at FVOCI | - 37 | - 10 | - 42 | - 39 | 9 |
| on goodwill | 0 | 0 | 0 | 0 | 0 |
| other | 0 | - 18 | - 16 | - 1 | 2 |
| Share in results of associated companies and joint ventures | 0 | 1 | 0 | - 1 | - 2 |
| RESULT BEFORE TAX | 380 | 630 | 682 | 766 | 438 |
| Income tax expense | - 137 | - 156 | - 164 | - 191 | - 139 |
| RESULT AFTER TAX | 242 | 474 | 517 | 575 | 299 |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | 243 | 474 | 517 | 576 | 299 |
| Banking | 143 | 392 | 414 | 448 | 214 |
| Insurance | 99 | 82 | 103 | 128 | 85 |
| Breakdown Loans and deposits | |||||
| Total customer loans excluding reverse repos (end of period) | 119 331 | 119 168 | 118 189 | 118 345 | 116 698 |
| of which Mortgage loans (end of period) | 45 397 | 45 394 | 45 147 | 45 031 | 44 627 |
| Customer deposits and debt certificates excl. repos (end of period) | 157 665 | 154 238 | 155 868 | 160 503 | 147 749 |
| Insurance related liabilities (including Inv. Contracts) | |||||
| Life insurance | 26 213 | 25 572 | 24 070 | 24 483 | 23 950 |
| Liabilities under investment contracts (IFRS 9) | 14 319 | 13 461 | 12 655 | 12 751 | 12 164 |
| Insurance contract liabilities (IFRS 17) | 11 894 | 12 111 | 11 415 | 11 732 | 11 787 |
| Non-life insurance | 2 282 | 2 204 | 2 139 | 2 173 | 2 177 |
| Performance Indicators | |||||
| Risk-weighted assets, banking (Basel III fully loaded, end of period) | 63 063 | 62 030 | 64 014 | 57 399 | 56 186 |
| Required capital, insurance (end of period) | 1 785 | 1 694 | 1 702 | 1 679 | 1 634 |
| Allocated capital (end of period) | 8 672 | 8 728 | 8 961 | 8 188 | 8 006 |
| Return on allocated capital (ROAC, YTD) | 11% | 22% | 23% | 22% | 15% |
| Cost/income ratio without banking and insurance tax (YTD) | 41% | 41% | 40% | 40% | 40% |
| Combined ratio, non-life insurance (YTD) | 86% | 85% | 83% | 82% | 81% |
| Net interest margin, banking (QTD) | 1.94% | 1.90% | 1.91% | 2.05% | 1.91% |
| Business unit Czech Republic | |||||
|---|---|---|---|---|---|
| (in millions of EUR) | 1Q 2024 | 4Q 2023 | 3Q 2023 | 2Q 2023 | 1Q 2023 |
| Breakdown P&L | |||||
| Net interest income | 315 | 322 | 316 | 325 | 309 |
| Insurance revenues before reinsurance | 138 | 142 | 143 | 139 | 132 |
| Non-life | 114 | 117 | 119 | 115 | 109 |
| Life | 24 | 25 | 24 | 24 | 23 |
| Dividend income | 0 | 0 | 0 | 0 | 0 |
| Net result from financial instruments at fair value through profit or loss & | |||||
| Insurance finance income and expense (for contracts issued) | 22 | 13 | 11 | 18 | 22 |
| Net fee and commission income | 84 | 81 | 81 | 83 | 80 |
| Net other income | 5 | 3 | - 5 | 5 | 2 |
| TOTAL INCOME | 564 | 560 | 546 | 569 | 544 |
| Operating expenses (excl. Opex allocated to insurance service expenses) | - 229 | - 210 | - 203 | - 199 | - 253 |
| Total Opex without bank and insurance tax | - 220 | - 237 | - 231 | - 228 | - 220 |
| Total bank and insurance tax | - 35 | 0 | 0 | 1 | - 60 |
| Minus: Opex allocated to insurance service expenses | 26 | 27 | 29 | 28 | 28 |
| Insurance service expenses before reinsurance | - 99 | - 113 | - 108 | - 109 | - 90 |
| Of which Insurance commissions paid | - 17 | - 21 | - 16 | - 15 | - 14 |
| Non-life | - 86 | - 100 | - 94 | - 95 | - 79 |
| of which Non-life - Claim related expenses | - 49 | - 57 | - 55 | - 57 | - 43 |
| Life | - 13 | - 13 | - 14 | - 15 | - 11 |
| Net result from reinsurance contracts held | - 4 | - 2 | - 5 | 0 | - 9 |
| Impairment | - 4 | - 114 | - 3 | 53 | 6 |
| on FA at amortised cost and at FVOCI | - 4 | 14 | - 4 | 53 | 7 |
| on goodwill | 0 | - 109 | 0 | 0 | 0 |
| other | 0 | - 19 | 0 | 0 | 0 |
| Share in results of associated companies and joint ventures | 0 | - 1 | 0 | 0 | 0 |
| RESULT BEFORE TAX | 229 | 121 | 228 | 314 | 198 |
| Income tax expense | - 33 | - 19 | - 27 | - 37 | - 14 |
| RESULT AFTER TAX | 197 | 102 | 200 | 276 | 184 |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | 197 | 102 | 200 | 276 | 184 |
| Banking | 164 | 73 | 172 | 248 | 153 |
| Insurance | 32 | 29 | 28 | 29 | 32 |
| Breakdown Loans and deposits | |||||
| Total customer loans excluding reverse repos (end of period) | 36 262 | 36 470 | 36 530 | 36 792 | 36 609 |
| of which Mortgage loans (end of period) | 19 283 | 19 641 | 19 796 | 20 184 | 20 313 |
| Customer deposits and debt certificates excl. repos (end of period) | 51 435 | 52 642 | 54 569 | 54 798 | 54 569 |
| Insurance related liabilities (including Inv. Contracts) | |||||
| Life insurance | 891 | 931 | 927 | 971 | 975 |
| Liabilities under investment contracts (IFRS 9) | 0 | 0 | 0 | 0 | 0 |
| Insurance contract liabilities (IFRS 17) | 891 | 931 | 927 | 971 | 975 |
| Non-life insurance | 343 | 357 | 347 | 342 | 336 |
| Performance Indicators | |||||
| Risk-weighted assets, banking (Basel III fully loaded, end of period) | 17 488 | 17 515 | 17 647 | 17 738 | 17 625 |
| Required capital, insurance (end of period) | 163 | 165 | 170 | 172 | 175 |
| Allocated capital (end of period) | 2 073 | 2 152 | 2 171 | 2 183 | 2 173 |
| Return on allocated capital (ROAC, YTD) | 38% | 35% | 40% | 42% | 34% |
| Cost/income ratio without banking and insurance tax (YTD) | 42% | 44% | 44% | 43% | 43% |
| Combined ratio, non-life insurance (YTD) | 79% | 84% | 83% | 82% | 82% |
| Net interest margin, banking (QTD) | 2.39% | 2.29% | 2.26% | 2.35% | 2.30% |
| Business unit International Markets | |||||
|---|---|---|---|---|---|
| (in millions of EUR) | 1Q 2024 | 4Q 2023 | 3Q 2023 | 2Q 2023 | 1Q 2023 |
| Breakdown P&L | |||||
| Net interest income | 324 | 308 | 296 | 291 | 284 |
| Insurance revenues before reinsurance | 130 | 122 | 122 | 117 | 111 |
| Non-life | 116 | 109 | 109 | 104 | 98 |
| Life | 15 | 13 | 14 | 13 | 13 |
| Dividend income | 0 | 0 | 0 | 1 | 0 |
| Net result from financial instruments at fair value through profit or loss & Insurance finance income and expense (for contracts issued) |
26 | 8 | 15 | 19 | 13 |
| Net fee and commission income | 122 | 127 | 124 | 125 | 116 |
| Net other income | 6 | 0 | 5 | 5 | 5 |
| TOTAL INCOME | 608 | 566 | 562 | 558 | 530 |
| Operating expenses (excl. Opex allocated to insurance service expenses) | - 326 | - 222 | - 218 | - 218 | - 305 |
| Total Opex without bank and insurance tax | - 200 | - 219 | - 209 | - 194 | - 183 |
| Total bank and insurance tax | - 167 | - 28 | - 29 | - 47 | - 158 |
| Minus: Opex allocated to insurance service expenses | 41 | 26 | 20 | 22 | 36 |
| Insurance service expenses before reinsurance | - 125 | - 114 | - 104 | - 100 | - 96 |
| Of which Insurance commissions paid | - 15 | - 16 | - 14 | - 13 | - 12 |
| Non-life | - 116 | - 105 | - 97 | - 93 | - 89 |
| of which Non-life - Claim related expenses | - 55 | - 62 | - 58 | - 54 | - 37 |
| Life | - 9 | - 9 | - 7 | - 7 | - 7 |
| Net result from reinsurance contracts held | 0 | - 1 | - 4 | - 5 | - 5 |
| Impairment | 20 | - 24 | - 5 | - 11 | 3 |
| on FA at amortised cost and at FVOCI | 20 | 1 | 7 | 8 | 4 |
| on goodwill | 0 | 0 | 0 | 0 | 0 |
| other | 0 | - 25 | - 11 | - 19 | 0 |
| Share in results of associated companies and joint ventures | 0 | 0 | 0 | 0 | 0 |
| RESULT BEFORE TAX | 177 | 206 | 232 | 223 | 128 |
| Income tax expense | - 30 | - 27 | - 32 | - 33 | - 20 |
| RESULT AFTER TAX | 146 | 178 | 200 | 190 | 108 |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | 146 | 178 | 200 | 190 | 108 |
| Banking | 141 | 171 | 185 | 178 | 96 |
| Insurance | 6 | 7 | 14 | 12 | 12 |
| Breakdown Loans and deposits | |||||
| Total customer loans excluding reverse repos (end of period) | 28 129 | 27 975 | 27 101 | 26 865 | 26 210 |
| of which Mortgage loans (end of period) | 10 631 | 10 447 | 10 162 | 10 040 | 9 871 |
| Customer deposits and debt certificates excl. repos (end of period) | 31 702 | 31 687 | 29 959 | 29 879 | 29 577 |
| Insurance related liabilities (including Inv. Contracts) | |||||
| Life insurance | 833 | 820 | 757 | 750 | 701 |
| Liabilities under investment contracts (IFRS 9) | 0 | 0 | 0 | 0 | 0 |
| Insurance contract liabilities (IFRS 17) | 833 | 820 | 757 | 750 | 701 |
| Non-life insurance | 345 | 343 | 317 | 307 | 292 |
| Performance Indicators | |||||
| Risk-weighted assets, banking (Basel III fully loaded, end of period) | 23 082 | 22 980 | 22 584 | 22 624 | 22 562 |
| Required capital, insurance (end of period) | 171 | 167 | 160 | 163 | 155 |
| Allocated capital (end of period) | 2 691 | 2 773 | 2 721 | 2 729 | 2 713 |
| Return on allocated capital (ROAC, YTD) | 22% | 25% | 25% | 22% | 16% |
| Cost/income ratio without banking and insurance tax (YTD) | 35% | 39% | 38% | 37% | 37% |
| Combined ratio, non-life insurance (YTD) | 102% | 97% | 96% | 97% | 97% |
| Net interest margin, banking (QTD) | 3.40% | 3.27% | 3.21% | 3.26% | 3.31% |
Note: The combined ratio, non-life insurance includes a significant windfall tax fully booked in first quarter. Excluding the windfall tax, the combined ratio amounted to 88% in 1Q24, 94% in 2023, 92% in 9M 2023. 90% in 1H 2023 and 83% in 1Q 2023
| Slovakia | |||||
|---|---|---|---|---|---|
| (in millions of EUR) | 1Q 2024 | 4Q 2023 | 3Q 2023 | 2Q 2023 | 1Q 2023 |
| Breakdown P&L | |||||
| Net interest income | 67 | 65 | 60 | 64 | 65 |
| Insurance revenues before reinsurance | 26 | 25 | 25 | 23 | 23 |
| Non-life | 21 | 20 | 21 | 19 | 18 |
| Life | 5 | 4 | 4 | 4 | 4 |
| Dividend income | 0 | 0 | 0 | 0 | 0 |
| Net result from financial instruments at fair value through profit or loss & | |||||
| Insurance finance income and expense (for contracts issued) | 3 | - 6 | 3 | 3 | 0 |
| Net fee and commission income | 21 | 22 | 21 | 21 | 20 |
| Net other income | 3 | 2 | 5 | 2 | 2 |
| TOTAL INCOME | 121 | 108 | 113 | 115 | 110 |
| Operating expenses (excl. Opex allocated to insurance service expenses) | - 64 | - 59 | - 57 | - 55 | - 58 |
| Total Opex without bank and insurance tax | - 62 | - 66 | - 63 | - 60 | - 60 |
| Total bank and insurance tax | - 9 | 0 | 0 | 1 | - 4 |
| Minus: Opex allocated to insurance service expenses | 7 | 7 | 6 | 5 | 7 |
| Insurance service expenses before reinsurance | - 24 | - 30 | - 22 | - 19 | - 19 |
| Of which Insurance commissions paid | - 3 | - 4 | - 2 | - 2 | - 2 |
| Non-life | - 21 | - 27 | - 20 | - 17 | - 16 |
| of which Non-life - Claim related expenses | - 13 | - 18 | - 13 | - 10 | - 10 |
| Life | - 3 | - 3 | - 2 | - 2 | - 3 |
| Net result from reinsurance contracts held | - 1 | 4 | - 1 | - 2 | - 1 |
| Impairment | 11 | 0 | - 2 | 9 | - 1 |
| on FA at amortised cost and at FVOCI | 11 | 2 | - 2 | 9 | - 1 |
| on goodwill | 0 | 0 | 0 | 0 | 0 |
| other | 0 | - 2 | 0 | 0 | 0 |
| Share in results of associated companies and joint ventures | 0 | 0 | 0 | 0 | 0 |
| RESULT BEFORE TAX | 43 | 24 | 32 | 48 | 31 |
| Income tax expense | - 9 | - 6 | - 7 | - 11 | - 6 |
| RESULT AFTER TAX | 34 | 18 | 25 | 37 | 24 |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | 34 | 18 | 25 | 37 | 24 |
| Banking | 33 | 18 | 23 | 35 | 22 |
| Insurance | 1 | 0 | 2 | 2 | 2 |
| Breakdown Loans and deposits | |||||
| Total customer loans excluding reverse repos (end of period) | 11 625 | 11 589 | 11 433 | 11 359 | 11 168 |
| of which Mortgage loans (end of period) | 6 504 | 6 451 | 6 373 | 6 303 | 6 217 |
| Customer deposits and debt certificates excl. repos (end of period) | 8 830 | 8 836 | 8 491 | 8 375 | 8 156 |
| Insurance related liabilities (including Inv. Contracts) | |||||
| Life insurance | 165 | 168 | 154 | 159 | 164 |
| Liabilities under investment contracts (IFRS 9) | 0 | 0 | 0 | 0 | 0 |
| Insurance contract liabilities (IFRS 17) | 165 | 168 | 154 | 159 | 164 |
| Non-life insurance | 59 | 58 | 51 | 48 | 47 |
| Performance Indicators | |||||
| Risk-weighted assets, banking (Basel III fully loaded, end of period) | 7 817 | 7 911 | 6 451 | 6 512 | 6 508 |
| Required capital, insurance (end of period) | 30 | 29 | 28 | 28 | 28 |
| Allocated capital (end of period) | 884 | 926 | 760 | 766 | 766 |
| Return on allocated capital (ROAC, YTD) | 15% | 13% | 15% | 16% | 13% |
| Cost/income ratio without banking and insurance tax (YTD) | 54% | 58% | 56% | 56% | 57% |
| Combined ratio, non-life insurance (YTD) | 107% | 101% | 97% | 96% | 93% |
| Hungary | |||||
|---|---|---|---|---|---|
| (in millions of EUR) | 1Q 2024 | 4Q 2023 | 3Q 2023 | 2Q 2023 | 1Q 2023 |
| Breakdown P&L | |||||
| Net interest income | 149 | 140 | 132 | 127 | 130 |
| Insurance revenues before reinsurance | 52 | 48 | 48 | 47 | 46 |
| Non-life | 47 | 43 | 43 | 42 | 41 |
| Life | 5 | 5 | 5 | 5 | 5 |
| Dividend income | 0 | 0 | 0 | 0 | 0 |
| Net result from financial instruments at fair value through profit or loss & | |||||
| Insurance finance income and expense (for contracts issued) | 22 | 14 | 11 | 15 | 12 |
| Net fee and commission income | 63 | 69 | 66 | 66 | 58 |
| Net other income | 3 | - 3 | - 2 | 1 | 1 |
| TOTAL INCOME | 289 | 267 | 256 | 256 | 247 |
| Operating expenses (excl. Opex allocated to insurance service expenses) | - 179 | - 93 | - 93 | - 110 | - 168 |
| Total Opex without bank and insurance tax | - 69 | - 75 | - 71 | - 68 | - 60 |
| Total bank and insurance tax | - 137 | - 28 | - 29 | - 52 | - 130 |
| Minus: Opex allocated to insurance service expenses | 27 | 10 | 7 | 10 | 23 |
| Insurance service expenses before reinsurance | - 66 | - 44 | - 45 | - 47 | - 49 |
| Of which Insurance commissions paid | - 2 | - 3 | - 3 | - 3 | - 2 |
| Non-life | - 63 | - 41 | - 42 | - 44 | - 46 |
| of which Non-life - Claim related expenses | - 25 | - 22 | - 24 | - 25 | - 14 |
| Life | - 3 | - 3 | - 3 | - 3 | - 3 |
| Net result from reinsurance contracts held | 5 | - 1 | - 1 | - 1 | - 1 |
| Impairment | 11 | - 21 | - 4 | - 24 | 11 |
| on FA at amortised cost and at FVOCI | 10 | - 1 | 6 | - 5 | 11 |
| on goodwill | 0 | 0 | 0 | 0 | 0 |
| other | 0 | - 20 | - 10 | - 19 | 0 |
| Share in results of associated companies and joint ventures | 0 | 0 | 0 | 0 | 0 |
| RESULT BEFORE TAX | 60 | 108 | 113 | 75 | 40 |
| Income tax expense | - 10 | - 14 | - 16 | - 12 | - 8 |
| RESULT AFTER TAX | 50 | 94 | 96 | 63 | 32 |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | 50 | 94 | 96 | 63 | 32 |
| Banking | 58 | 91 | 94 | 63 | 34 |
| Insurance | - 8 | 3 | 2 | 0 | - 2 |
| Breakdown Loans and deposits | |||||
| Total customer loans excluding reverse repos (end of period) | 6 640 | 6 764 | 6 445 | 6 548 | 6 334 |
| of which Mortgage loans (end of period) | 1 815 | 1 818 | 1 754 | 1 796 | 1 766 |
| Customer deposits and debt certificates excl. repos (end of period) | 9 577 | 9 610 | 8 881 | 9 305 | 9 302 |
| Insurance related liabilities (including Inv. Contracts) | |||||
| Life insurance | 305 | 299 | 285 | 289 | 268 |
| Liabilities under investment contracts (IFRS 9) | 0 | 0 | 0 | 0 | 0 |
| Insurance contract liabilities (IFRS 17) | 305 | 299 | 285 | 289 | 268 |
| Non-life insurance | 117 | 114 | 104 | 104 | 91 |
| Performance Indicators | |||||
| Risk-weighted assets, banking (Basel III fully loaded, end of period) | 6 641 | 6 646 | 8 240 | 8 347 | 8 540 |
| Required capital, insurance (end of period) | 58 | 59 | 54 | 54 | 53 |
| Allocated capital (end of period) | 784 | 812 | 989 | 1 001 | 1 022 |
| Return on allocated capital (ROAC, YTD) | 25% | 30% | 26% | 19% | 13% |
| Cost/income ratio without banking and insurance tax (YTD) | 25% | 28% | 27% | 27% | 25% |
| Combined ratio, non-life insurance (YTD) | 124% | 105% | 108% | 111% | 115% |
Note: The combined ratio, non-life insurance includes a significant windfall tax fully booked in first quarter. Excluding the windfall tax, the combined ratio amounted to 89% in 1Q 2024 ,97% in 2023 & 9M 2023, 95% in 1H 2023 and 83% in 1Q 2023.
| Bulgaria | |||||
|---|---|---|---|---|---|
| (in millions of EUR) | 1Q 2024 | 4Q 2023 | 3Q 2023 | 2Q 2023 | 1Q 2023 |
| Breakdown P&L | |||||
| Net interest income | 107 | 103 | 104 | 99 | 90 |
| Insurance revenues before reinsurance | 53 | 50 | 50 | 47 | 43 |
| Non-life | 48 | 45 | 45 | 43 | 39 |
| Life | 5 | 5 | 4 | 4 | 4 |
| Dividend income | 0 | 0 | 0 | 1 | 0 |
| Net result from financial instruments at fair value through profit or loss & | |||||
| Insurance finance income and expense (for contracts issued) | 0 | 0 | 1 | 1 | 1 |
| Net fee and commission income | 37 | 37 | 37 | 37 | 37 |
| Net other income | 0 | 1 | 1 | 1 | 2 |
| TOTAL INCOME | 197 | 192 | 193 | 187 | 172 |
| Operating expenses (excl. Opex allocated to insurance service expenses) | - 83 | - 70 | - 68 | - 54 | - 79 |
| Total Opex without bank and insurance tax | - 70 | - 78 | - 75 | - 65 | - 62 |
| Total bank and insurance tax | - 21 | 0 | 0 | 4 | - 24 |
| Minus: Opex allocated to insurance service expenses | 8 | 9 | 7 | 7 | 7 |
| Insurance service expenses before reinsurance | - 35 | - 40 | - 37 | - 34 | - 27 |
| Of which Insurance commissions paid | - 9 | - 9 | - 8 | - 8 | - 7 |
| Non-life | - 32 | - 38 | - 35 | - 32 | - 27 |
| of which Non-life - Claim related expenses | - 17 | - 22 | - 21 | - 18 | - 14 |
| Life | - 3 | - 3 | - 2 | - 2 | - 1 |
| Net result from reinsurance contracts held | - 4 | - 4 | - 3 | - 3 | - 3 |
| Impairment | - 2 | - 3 | 2 | 4 | - 6 |
| on FA at amortised cost and at FVOCI | - 2 | - 1 | 3 | 4 | - 6 |
| on goodwill | 0 | 0 | 0 | 0 | 0 |
| other | 0 | - 3 | - 1 | 0 | 0 |
| Share in results of associated companies and joint ventures | 0 | 0 | 0 | 0 | 0 |
| RESULT BEFORE TAX | 74 | 74 | 88 | 100 | 57 |
| Income tax expense | - 11 | - 7 | - 9 | - 10 | - 6 |
| RESULT AFTER TAX | 63 | 67 | 79 | 90 | 51 |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | 63 | 67 | 79 | 90 | 51 |
| Banking | 50 | 62 | 69 | 80 | 39 |
| Insurance | 13 | 4 | 10 | 10 | 12 |
| Breakdown Loans and deposits | |||||
| Total customer loans excluding reverse repos (end of period) | 9 864 | 9 623 | 9 223 | 8 959 | 8 708 |
| of which Mortgage loans (end of period) | 2 312 | 2 178 | 2 035 | 1 942 | 1 888 |
| Customer deposits and debt certificates excl. repos (end of period) | 13 295 | 13 241 | 12 588 | 12 199 | 12 119 |
| Insurance related liabilities (including Inv. Contracts) | |||||
| Life insurance | 364 | 353 | 319 | 303 | 269 |
| Liabilities under investment contracts (IFRS 9) | 0 | 0 | 0 | 0 | 0 |
| Insurance contract liabilities (IFRS 17) | 364 | 353 | 319 | 303 | 269 |
| Non-life insurance | 169 | 171 | 162 | 156 | 154 |
| Performance Indicators | |||||
| Risk-weighted assets, banking (Basel III fully loaded, end of period) | 8 623 | 8 423 | 7 892 | 7 765 | 7 513 |
| Required capital, insurance (end of period) | 83 | 80 | 77 | 82 | 73 |
| Allocated capital (end of period) | 1 024 | 1 035 | 972 | 962 | 925 |
| Return on allocated capital (ROAC, YTD) | 25% | 30% | 31% | 30% | 22% |
| Cost/income ratio without banking and insurance tax (YTD) | 40% | 42% | 41% | 40% | 40% |
| Combined ratio, non-life insurance (YTD) | 79% | 87% | 83% | 82% | 79% |
| Business unit Group Centre | |||||
|---|---|---|---|---|---|
| (in millions of EUR) | 1Q 2024 | 4Q 2023 | 3Q 2023 | 2Q 2023 | 1Q 2023 |
| Breakdown P&L | |||||
| Net interest income | - 79 | - 79 | - 41 | - 66 | - 39 |
| Insurance revenues before reinsurance | 4 | 4 | 4 | 4 | 2 |
| Non-life | 4 | 4 | 4 | 4 | 2 |
| Life | 0 | 0 | 0 | 0 | 0 |
| Dividend income | 0 | 1 | 2 | 1 | 0 |
| Net result from financial instruments at fair value through profit or loss & Insurance finance income and expense (for contracts issued) |
- 1 | 25 | 13 | 33 | 18 |
| Net fee and commission income | - 1 | - 1 | - 1 | - 2 | - 2 |
| Net other income | - 7 | - 1 | 1 | - 4 | 404 |
| TOTAL INCOME | - 85 | - 52 | - 22 | - 34 | 384 |
| Operating expenses (excl. Opex allocated to insurance service expenses) | - 36 | - 70 | - 35 | - 57 | - 95 |
| Total Opex without bank and insurance tax | - 37 | - 70 | - 36 | - 58 | - 90 |
| Total bank and insurance tax | 1 | 0 | 0 | 1 | - 5 |
| Minus: Opex allocated to insurance service expenses | 1 | 0 | 1 | 1 | 1 |
| Insurance service expenses before reinsurance | 1 | 1 | - 1 | 0 | - 1 |
| Of which Insurance commissions paid | 0 | 0 | 0 | 0 | 0 |
| Non-life | 1 | 1 | - 1 | 0 | - 1 |
| of which Non-life - Claim related expenses | 2 | 2 | - 1 | 1 | 0 |
| Life | 0 | 0 | 0 | 0 | 0 |
| Net result from reinsurance contracts held | 10 | 5 | - 6 | - 1 | 5 |
| Impairment | 4 | - 4 | 2 | - 10 | 5 |
| on FA at amortised cost and at FVOCI | 4 | 0 | 2 | 1 | 5 |
| other | 0 | - 4 | 0 | - 11 | 0 |
| Share in results of associated companies and joint ventures | 0 | 0 | 0 | 0 | 0 |
| RESULT BEFORE TAX | - 105 | - 120 | - 62 | - 102 | 299 |
| Income tax expense | 26 | 43 | 21 | 25 | - 7 |
| RESULT AFTER TAX | - 80 | - 77 | - 41 | - 76 | 291 |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | - 80 | - 77 | - 41 | - 76 | 291 |
| Banking | - 92 | - 71 | - 50 | - 85 | 292 |
| Insurance | - 4 | - 9 | - 11 | - 9 | - 3 |
| Holding activities | 16 | 3 | 20 | 17 | 2 |
| Breakdown Loans and deposits | |||||
| Total customer loans excluding reverse repos (end of period) | 0 | 0 | 2 | 3 | 3 |
| of which Mortgage loans (end of period) | 0 | 0 | 0 | 0 | 0 |
| Customer deposits and debt certificates excl. repos (end of period) | 22 898 | 20 924 | 19 986 | 18 988 | 16 987 |
| Performance Indicators | |||||
| Risk-weighted assets, banking (end of period, Basel III fully loaded) | 1 335 | 1 380 | 1 876 | 2 051 | 2 179 |
| Risk-weighted assets, insurance (end of period, Basel III fully loaded) | 9 133 | 9 133 | 9 133 | 9 133 | 9 133 |
| Required capital, insurance (end of period) | - 65 | - 22 | 2 | 2 | 1 |
| Allocated capital (end of period) | 81 | 134 | 215 | 234 | 248 |
Regarding the contribution of KBC Bank Ireland, see note 6.6 in this report.
Gives an idea of the amount of profit over a certain period that is attributable to one share (and, where applicable, including dilutive instruments).
| Calculation (in millions of EUR) | Reference | 1Q 2024 | 2023 | 1Q 2023 |
|---|---|---|---|---|
| Result after tax, attributable to equity holders of the parent (A) |
'Consolidated income statement' | 506 | 3 402 | 882 |
| - | ||||
| Coupon on the additional tier-1 instruments included in equity (B) |
'Consolidated statement of changes in equity' | - 25 | - 64 | - 12 |
| / | ||||
| Average number of ordinary shares less treasury shares (in millions) in the period (C) |
Note 5.10 | 406 | 415 | 417 |
| or | ||||
| Average number of ordinary shares plus dilutive options less treasury shares in the period (D) |
406 | 415 | 417 | |
| Basic = (A-B) / (C) (in EUR) | 1.18 | 8.04 | 2.08 | |
| Diluted = (A-B) / (D) (in EUR) | 1.18 | 8.04 | 2.08 | |
Gives insight into the technical profitability of the short-term non-life insurance business, more particularly the extent to which insurance premiums adequately cover claim payments and expenses. The combined ratio is defined net of reinsurance.
| Calculation (in millions of EUR or %) | Reference | 1Q 2024 | 2023 | 1Q 2023 |
|---|---|---|---|---|
| Non-life PAA – Claims and claim related costs net of reinsurance (A) |
Note 3.6, component of 'Insurance revenues before reinsurance' & of 'Net result from reinsurance contracts held' |
309 | 1 204 | 266 |
| + | ||||
| Costs other than claims and commissions (B) | Note 3.6, component of 'Insurance Service Expenses' & of 'Non-directly attributable income and expenses' & of 'Net result from reinsurance contracts held' |
173 | 676 | 160 |
| / | ||||
| Non-life PAA - Net earned expected premiums received (C) | Note 3.6, component of 'Insurance revenues before reinsurance' & of 'Net result from reinsurance contracts held' |
565 | 2 160 | 514 |
| = (A+B) / (C) | 85.3% | 87.0% | 82.7% |
A risk-weighted measure of the group's solvency based on common equity tier-1 capital (the ratios given here are based on the Danish compromise). Changes to the capital rules are gradually being implemented to allow banks to build up the necessary capital buffers. The capital position of a bank, when account is taken of the transition period, is referred to as the 'transitional' view. The capital position based on full application of all the rules – as would be the case after this transition period – is referred to as 'fully loaded'.
A detailed calculation can be found under 'Solvency KBC Group' section.
Gives an impression of the relative cost efficiency (costs relative to income without banking and insurance tax, but including insurance commissions paid) of the group.
| Calculation (in millions of EUR or %) | Reference | 1Q 2024 | 2023 | 1Q 2023 |
|---|---|---|---|---|
| Cost/income ratio | ||||
| Total Opex without banking and insurance tax (A) + |
Consolidated income statement | 1 063 | 4 438 | 1 077 |
| Insurance commissions paid (B) | Note 3.6, component of 'Insurance Service Expenses' |
89 | 340 | 77 |
| / | ||||
| Total income (C) | Consolidated income statement | 2 708 | 11 224 | 3 060 |
| =(A+B) / (C) | 42.5% | 42.6% | 37.7% |
Where relevant, we also exclude the exceptional and/or non-operating items when calculating the cost/income ratio. This calculation aims to give a better idea of the relative cost efficiency of the pure business activities. The adjustments include: MTM ALM derivatives (fully excluded), bank and insurance taxes (including contributions to European Single Resolution Fund) are included pro rata and hence spread over all quarters of the year instead of being recognised for the most part upfront (as required by IFRIC 21) and one-off items. The Cost/Income ratio adjusted for specific items is 46% in 1Q 2024 (versus 49% in 2023 and 50% in 1Q 2023).
Indicates the proportion of impaired loans (see 'Impaired loans ratio' for definition) that are covered by impairment charges. The numerator and denominator in the formula relate to all impaired loans, but may be limited to impaired loans that are more than 90 days past due (the figures for that particular calculation are given in the 'Credit risk' section.
| Calculation (in millions of EUR or %) | Reference | 1Q 2024 | 2023 | 1Q 2023 |
|---|---|---|---|---|
| Stage 3 impairment on loans (A) | 'Credit risk: loan portfolio overview' table in the 'Credit risk' section |
1 915 | 1 888 | 1 867 |
| / | ||||
| Outstanding impaired loans (B) | 'Credit risk: loan portfolio overview' table in the 'Credit risk' section |
4 299 | 4 221 | 4 026 |
| = (A) / (B) | 44.5% | 44.7% | 46.4% |
Gives an idea of loan impairment charges recognised in the income statement for a specific period, relative to the total loan portfolio (see 'Loan portfolio' for definition). In the longer term, this ratio can provide an indication of the credit quality of the portfolio.
| Calculation (in millions of EUR or %) | Reference | 1Q 2024 | 2023 | 1Q 2023 |
|---|---|---|---|---|
| Net changes in impairment for credit risks (A) |
'Consolidated income statement': component of 'Impairment' |
22 | - 9 | - 20 |
| / | ||||
| Average outstanding loan portfolio (B) | 'Credit risk: loan portfolio overview' table in the 'Credit risk' section |
202 590 | 200 270 | 199 498 |
| = (A) (annualised) / (B) | 0.04% | 0.00% | -0.04% |
*based on YTD view
In 1Q 2024, the credit cost ratio without the outstanding ECL for geopolitical and macroeconomic uncertainties, amounts to 0.10% (versus 0.07% in 2023 and 0.00% in 1Q 2023).
Indicates the proportion of impaired loans in the loan portfolio (see 'Loan portfolio' for definition) and, therefore, gives an idea of the creditworthiness of the portfolio. Impaired loans are loans where it is unlikely that the full contractual principal and interest will be repaid/paid. These loans have a KBC default status of PD 10, PD 11 or PD 12. Where appropriate, the numerator in the formula may be limited to impaired loans that are more than 90 days past due (PD 11 + PD 12). Relevant figures for that calculation are given in the 'Credit Risk' section.
| Calculation (in millions of EUR or %) | Reference | 1Q 2024 | 2023 | 1Q 2023 |
|---|---|---|---|---|
| Amount outstanding of impaired loans (A) | 'Credit risk: loan portfolio overview' table in the 'Credit risk' section |
4 299 | 4 221 | 4 026 |
| / | ||||
| Total outstanding loan portfolio (B) | 'Credit risk: loan portfolio overview in the 'Credit risk' section |
202 226 | 202 953 | 201 409 |
| = (A) / (B) | 2.1% | 2.1% | 2.0% |
Gives an idea of the group's solvency, based on a simple non-risk-weighted ratio. A detailed calculation can be found under 'Solvency KBC Group' section.
Gives an idea of the bank's liquidity position in the short term, more specifically the extent to which the group is able to overcome liquidity difficulties over a one-month period. It is the average of 12 end-of-month LCR figures.
| Calculation (in millions of EUR or %) | Reference | 1Q 2024 | 2023 | 1Q 2023 |
|---|---|---|---|---|
| Stock of high-quality liquid assets (A) | Based on the European Commission's Delegated Act on LCR and the European Banking Authority's guidelines for LCR disclosure |
102 401 | 101 555 | 91 145 |
| / | ||||
| Total net cash outflows over the next 30 calendar days (B) |
63 370 | 63 805 | 60 320 | |
| = (A) / (B) | 162% | 159% | 152% | |
KBCs large stock of high-quality liquid assets (approximately 102 billion euros in 1Q 2024), which consist of cash and bonds which can be repoed in the private market and at the central banks. Note that the 102bn EUR consist of:
Gives an idea of the magnitude of (what are mainly traditional) lending activities.
| Calculation (in millions of EUR or %) | Reference | 1Q 2024 | 2023 | 1Q 2023 |
|---|---|---|---|---|
| Loans and advances to customers (A) | Note 4.1, component of 'Loans and advances to customers' |
183 722 | 183 613 | 179 520 |
| + | ||||
| Reverse repos (not with Central Banks) (B) | Note 4.1, component of 'Reverse repos with credit institutions and investment firms' |
588 | 763 | 2 939 |
| + | ||||
| Debt instruments issued by corporates and by credit institutions and investment firms (banking) (C) |
Note 4.1, component of 'Debt instruments issued by corporates and by credit institutions and investment firms' |
6 606 | 6 681 | 6 711 |
| + | ||||
| Other exposures to credit institutions (D) | 3 520 | 3 301 | 3 764 | |
| + | ||||
| Financial guarantees granted to clients and other commitments (E) |
Note 6.1, component of 'Financial guarantees given' |
9 941 | 10 263 | 10 360 |
| + | ||||
| Impairment on loans (F) | Note 4.2, component of 'Impairment' |
2 443 | 2 483 | 2 603 |
| + | ||||
| Insurance entities (G) | Note 4.1, component of 'Loans and advances to customers' |
- 1 921 | - 1 927 | - 1 986 |
| + | ||||
| Non-loan-related receivables (H) | - 517 | - 528 | - 649 | |
| + | ||||
| Other (I) | Component of Note 4.1 | - 2 155 | - 1 694 | - 1 851 |
| Gross Carrying amount = (A)+(B)+(C)+(D)+(E)+(F)+(G)+(H)+(I) |
202 226 | 202 954 | 201 409 |
Gives an idea of the net interest income of the banking activities (one of the most important sources of revenue for the group) relative to the average total interest-bearing assets of the banking activities.
| Calculation (in millions of EUR or %) | Reference | 1Q 2024 | 2023 | 1Q 2023 |
|---|---|---|---|---|
| Net interest income of the banking activities (A) | 'Consolidated income statement': component of 'Net interest income' |
1 238 | 4 812 | 1 157 |
| / | ||||
| Average interest-bearing assets of the banking activities (B) | 'Consolidated balance sheet': component of 'Total assets' |
235 195 | 231 869 | 226 989 |
| = (A) (annualised x360/number of calendar days) / (B) | 2.08% | 2.05% | 2.04% |
The net interest margin is the net interest income of the banking activities, excluding dealing rooms and the net interest impact of ALM FX swaps and repos.
Gives an idea of the bank's structural liquidity position in the long term, more specifically the extent to which the group is able to overcome liquidity difficulties over a one-year period.
| Calculation (in millions of EUR or %) | Reference | 1Q 2024 | 2023 | 1Q 2023 |
|---|---|---|---|---|
| Available amount of stable funding (A) | Regulation (EU) 2019/876 dd. 20-05-2019 | 212 326 | 208 412 | 214 719 |
| / | ||||
| Required amount of stable funding (B) | 152 858 | 153 372 | 154 454 | |
| = (A) / (B) | 139% | 136% | 139% |
Gives the carrying value of a KBC share, i.e. the value in euros represented by each share in the parent shareholders' equity of KBC.
| Calculation (in millions of EUR or number) | Reference | 1Q 2024 | 2023 | 1Q 2023 |
|---|---|---|---|---|
| Parent shareholders' equity (A) | 'Consolidated balance sheet' | 22 166 | 22 010 | 21 641 |
| / | ||||
| Number of ordinary shares less treasury shares (at period-end) (B) |
Note 5.10 | 403 | 409 | 417 |
| = (A) / (B) (in EUR) | 54.94 | 53.88 | 51.88 |
KBC Group launched a share buyback program for the purpose of distributing the surplus capital from 11th August 2023 until 31st July 2024, for a maximum amount of 1.3 billion euros. At the end of March 2024, the total number of shares entitled to dividend reduced with 13 843 378 shares.
Gives an idea of the relative profitability of a business unit, more specifically the ratio of the net result to the capital allocated to the business unit.
| Calculation (in millions of EUR or %) | Reference | 1Q 2024 | 2023 | 1Q 2023 |
|---|---|---|---|---|
| BELGIUM BUSINESS UNIT | ||||
| Result after tax (including minority interests) of the business unit (A) |
Note 2.2: Results by segment | 243 | 1 866 | 299 |
| / | ||||
| The average amount of capital allocated to the business unit is based on the risk-weighted assets for the banking activities (under Basel III) and risk-weighted asset equivalents for the insurance activities (under Solvency II) (B) |
8 570 | 8 343 | 7 918 | |
| = (A) annualised / (B) | 11.3% | 22.4% | 15.1% | |
| CZECH REPUBLIC BUSINESS UNIT | ||||
| Result after tax (including minority interests) of the business unit (A) |
Note 2.2: Results by segment | 197 | 763 | 184 |
| / | ||||
| The average amount of capital allocated to the business unit is based on the risk-weighted assets for the banking activities (under Basel III) and risk-weighted asset equivalents for the insurance activities (under Solvency II) (B) |
2 075 | 2 165 | 2 159 | |
| = (A) annualised / (B) | 38.0% | 35.0% | 34.0% | |
| INTERNATIONAL MARKETS BUSINESS UNIT | ||||
| Result after tax (including minority interests) of the business unit (A) |
Note 2.2: Results by segment | 146 | 676 | 108 |
| / | ||||
| The average amount of capital allocated to the business unit is based on the risk-weighted assets for the banking activities (under Basel III) and risk-weighted asset equivalents for the insurance activities (under Solvency II) (B) |
2 684 | 2 705 | 2 651 | |
| = (A) annualised / (B) | 21.8% | 25.0% | 16.2% |
Gives an idea of the relative profitability of the group, more specifically the ratio of the net result to equity.
| Calculation (in millions of EUR or %) | Reference | 1Q 2024 | 2023 | 1Q 2023 |
|---|---|---|---|---|
| Result after tax, attributable to equity holders of the parent (A) |
'Consolidated income statement' | 506 | 3 402 | 882 |
| - | ||||
| Coupon on the additional tier-1 instruments included in equity (B) |
'Consolidated statement of changes in equity' | - 25 | - 64 | - 12 |
| / | ||||
| Average parent shareholders' equity (C) | 'Consolidated statement of changes in equity' | 22 088 | 21 164 | 20 980 |
| = (A-B) (annualised) / (C) | 8.7% | 15.8% | 16.6% |
In 1Q 2024, the return on equity amounts to 14% when including evenly spreading of the bank and insurance tax throughout the year and excluding one-offs.
Total sales of life insurance compromise new business of guaranteed interest contracts, unit-linked investment contracts and hybrid contracts.
| Calculation (in millions of EUR or %) | Reference | 1Q 2024 | 2023 | 1Q 2023 |
|---|---|---|---|---|
| Guaranteed Interest products | 261 | 979 | 248 | |
| + | ||||
| Unit-Linked products | 471 | 1 218 | 199 | |
| + | ||||
| Hybrid products | 33 | 131 | 31 | |
| Total sales Life (A)+ (B) + (C) | 765 | 2 328 | 477 |
Measures the solvency of the insurance business, as calculated under Solvency II.
A detailed calculation can be found under 'Solvency banking and insurance activities separately' section.
Total assets under management (AuM) consist of direct client money (Assets under Distribution towards retail, private banking and institutional clients), KBC Group assets (incl. pension fund), fund-of-funds assets and investment advice. Total AuM comprise assets managed by the group's various asset management companies (KBC Asset Management, ČSOB Asset Management, etc.), as well as assets under advisory management at KBC Bank. The size and development of total AuM are major factors behind net fee and commission income (generating entry and management fees) and hence determine a large part of any change in this income line.
| Calculation (in billions of EUR or quantity) | Reference | 1Q 2024 | 2023 | 1Q 2023 |
|---|---|---|---|---|
| Belgium Business Unit (A) | Company presentation on www.kbc.com | 230 | 218 | 193 |
| + | ||||
| Czech Republic Business Unit (B) | 18 | 17 | 16 | |
| + | ||||
| International Markets Business Unit (C) | 10 | 9 | 8 | |
| A)+(B)+(C) | 258 | 244 | 217 |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.